<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:43:59Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3326523" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3326523</identifier><datestamp>2012-04-16</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell</journal-id>
      <journal-title-group>
        <journal-title>Cell</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0092-8674</issn>
      <issn pub-type="epub">1097-4172</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3326523</article-id>
      <article-id pub-id-type="pmcid">PMC3326523</article-id>
      <article-id pub-id-type="pmc-uid">3326523</article-id>
      <article-id pub-id-type="pmid">22464331</article-id>
      <article-id pub-id-type="publisher-id">S0092-8674(12)00213-9</article-id>
      <article-id pub-id-type="doi">10.1016/j.cell.2012.02.013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Resource</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Filippakopoulos</surname>
            <given-names>Panagis</given-names>
          </name>
          <email>panagis.filippakopoulos@sgc.ox.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Picaud</surname>
            <given-names>Sarah</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mangos</surname>
            <given-names>Maria</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Keates</surname>
            <given-names>Tracy</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lambert</surname>
            <given-names>Jean-Philippe</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barsyte-Lovejoy</surname>
            <given-names>Dalia</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Felletar</surname>
            <given-names>Ildiko</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Volkmer</surname>
            <given-names>Rudolf</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MÃ¼ller</surname>
            <given-names>Susanne</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pawson</surname>
            <given-names>Tony</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gingras</surname>
            <given-names>Anne-Claude</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arrowsmith</surname>
            <given-names>CherylÂ H.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Knapp</surname>
            <given-names>Stefan</given-names>
          </name>
          <email>stefan.knapp@sgc.ox.ac.uk</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff8" ref-type="aff">8</xref>
          <xref rid="cor2" ref-type="corresp">ââ</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK</aff>
      <aff id="aff2"><label>2</label>Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK</aff>
      <aff id="aff3"><label>3</label>Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada</aff>
      <aff id="aff4"><label>4</label>Ontario Cancer Institute, Campbell Family Cancer Research Institute and Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada</aff>
      <aff id="aff5"><label>5</label>Centre for Systems Biology, Samuel Lunenfeld Research Institute, 600Â University Avenue, Toronto, Ontario M5G 1X5, Canada</aff>
      <aff id="aff6"><label>6</label>Institut fÃ¼r Medizinische Immunologie, CharitÃ©-UniversitÃ¤tsmedizin Berlin, Hessische Str. 3-4, 10115 Berlin, Germany</aff>
      <aff id="aff7"><label>7</label>Department of Molecular Genetics, University of Toronto, 1 Kings College Circle, Toronto, Ontario M5S 1A8, Canada</aff>
      <aff id="aff8"><label>8</label>Department of Biochemistry and Molecular Biology, George Washington University, School of Medicine and Health Sciences, 2300Â EyeÂ Street, NW, Suite 530, Washington, DC, 20037, USA</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>panagis.filippakopoulos@sgc.ox.ac.uk</email></corresp>
        <corresp id="cor2"><label>ââ</label>Corresponding author <email>stefan.knapp@sgc.ox.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>30</day>
        <month>3</month>
        <year>2012</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>30</day>
        <month>3</month>
        <year>2012</year>
      </pub-date>
      <volume>149</volume>
      <issue>1</issue>
      <fpage>214</fpage>
      <lpage>231</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>7</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>16</day>
          <month>10</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>1</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2012 ELL &amp; Excerpta Medica.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license xlink:href="https://creativecommons.org/licenses/by/3.0/">
          <license-p>Open Access under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">CC BY 3.0</ext-link> license</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>Bromodomains (BRDs) are protein interaction modules that specifically recognize Îµ-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening ofÂ more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <sec>
          <title>Graphical Abstract</title>
          <p>
            <fig id="dfig1" position="anchor">
              <graphic xlink:href="fx1"/>
            </fig>
          </p>
        </sec>
        <sec>
          <title>Highlights</title>
          <p>âº Human bromodomain family characterized with 29 high-resolution crystal structures âº Peptide arrays establish core histone binding preferences of BRD âº Interactions with histone-acetylated lysine sites are quantified âº Flanking posttranslational modifications greatly impact acetylated lysine recognition</p>
        </sec>
      </abstract>
      <abstract abstract-type="teaser">
        <p>Bromodomains bind acetylated lysines in histones, a key event in the âreadingâ of epigenetic marks. A foundation for designing inhibitors for this emerging class of drug targets is provided by a systematic biochemical analysis of their binding preferences and a compendium of 29 crystal structures of human bromodomains.</p>
      </abstract>
    </article-meta>
    <notes>
      <p>Published: March 29, 2012</p>
    </notes>
  </front>
  <body>
    <sec sec-type="intro" id="sec1">
      <title>Introduction</title>
      <p>Îµ-N-acetylation of lysine residues (K<sub>ac</sub>) is one of the most frequently occurring posttranslational modifications (PTMs) in proteins (<xref rid="bib9" ref-type="bibr">Choudhary etÂ al., 2009</xref>). Acetylation has a profound effect on the physiochemical properties of modified lysine residues neutralizing the positive charge of the Îµ-amino group (<xref rid="bib39" ref-type="bibr">Kouzarides, 2000</xref>). Lysine acetylation is abundant in large macromolecular complexes that function in chromatin remodeling, DNA damage, and cell-cycle control (<xref rid="bib9" ref-type="bibr">Choudhary etÂ al., 2009</xref>) and particularly in histones. Cellular acetylation levels are stringently controlled by two enzyme families: the histone acetyltransferases (HATs) and histone deacetylases (HDACs) (<xref rid="bib69" ref-type="bibr">Shahbazian and Grunstein, 2007</xref>). Histone acetylation has been associated with transcriptional activation, but specific marks have also been linked to DNA repair (<xref rid="bib40" ref-type="bibr">Kouzarides, 2007</xref>).</p>
      <p>Bromodomains (BRDs) are protein interaction modules that exclusively recognize acetylation motifs. BRDs are evolutionarily conserved and present in diverse nuclear proteins comprising HATs (GCN5, PCAF), ATP-dependent chromatin-remodeling complexes (BAZ1B), helicases (SMARCA), methyltransferases (MLL, ASH1L), transcriptional coactivators (TRIM/TIF1, TAFs) transcriptional mediators (TAF1), nuclear-scaffolding proteins (PB1), and the BET family (<xref rid="bib55" ref-type="bibr">Muller etÂ al., 2011</xref>) (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A and <xref rid="tbl1" ref-type="table">Table 1</xref>). Despite large sequence variations, all BRD modules share a conserved fold that comprises a left-handed bundle of four Î± helices (Î±<sub>Z</sub>, Î±<sub>A</sub>, Î±<sub>B</sub>, Î±<sub>C</sub>), linked by loop regions of variable length (ZA and BC loops), which line the K<sub>ac</sub> binding site and determine binding specificity. Cocrystal structures with peptides have demonstrated that K<sub>ac</sub> is recognized by a central deep hydrophobic cavity, where it is anchored by a hydrogen bond to an asparagine residue present in most BRDs (<xref rid="bib60" ref-type="bibr">Owen etÂ al., 2000</xref>).</p>
      <p>Dysfunction of BRD proteins has been linked to development of several diseases. For instance, recurrent t(15;19) chromosomal translocations that result in a fusion protein that comprises both BRD4 or BRD3 and the NUT (<italic>nu</italic>clear protein in <italic>t</italic>estis) lead to an aggressive form of human squamous carcinoma (<xref rid="bib21 bib23" ref-type="bibr">French, 2010a; French etÂ al., 2001</xref>). Deregulation of transcription as a consequence of altered protein acetylation patterns is a hallmark of cancer, a mechanism that is currently targeted by HDAC inhibitors (<xref rid="bib42" ref-type="bibr">Lane and Chabner, 2009</xref>). It is likely that selective inhibitors capable of targeting BRDs will find broad application in medicine and basic research as exemplified by the recent development of highly specific and potent acetyl-lysine competitive BET BRD inhibitors (<xref rid="bib10 bib12 bib13 bib18 bib50 bib58" ref-type="bibr">Chung etÂ al., 2011; Dawson etÂ al., 2011; Delmore etÂ al., 2011; Filippakopoulos etÂ al., 2010; Mertz etÂ al., 2011; Nicodeme etÂ al., 2010</xref>).</p>
      <p>To date, only a small number of lysine acetylation marks have been identified to specifically interact with individual BRDs, and the often weak affinities reported for BRD interactions with their potential target sites have been determined by a variety of different techniques making data comparison difficult (<xref rid="bib55" ref-type="bibr">Muller etÂ al., 2011</xref>). Reported affinities range from nano- to millimolar dissociation constant (K<sub>D</sub>) values raising the issue of which affinity window is relevant for specific BRD-peptide interactions. For instance, the BRDs of BRD2 have been shown to bind histone 4 acetylated at lysine 12 (H4K12<sub>ac</sub>) (<xref rid="bib37" ref-type="bibr">Kanno etÂ al., 2004</xref>), with K<sub>D</sub> values that range from 360Â Î¼M for the diacetylated peptide H4K5<sub>ac</sub>K12<sub>ac</sub> (<xref rid="bib75" ref-type="bibr">Umehara etÂ al., 2010</xref>) to 2.9Â mM for the monoacetylated H4K12<sub>ac</sub> peptide (<xref rid="bib30" ref-type="bibr">Huang etÂ al., 2007</xref>). Closely spaced multiple K<sub>ac</sub> sites have also been shown to significantly increase affinity of the histone H4Â N terminus for BRDT by simultaneous binding to the same BRD (<xref rid="bib51" ref-type="bibr">MoriniÃ¨re etÂ al., 2009</xref>). Thus, the field would greatly benefit from a more systematic analysis ofÂ BRD structure and peptide binding properties in order to better understand acetylation-mediated signaling as interpreted through BRDs.</p>
      <p>Here, we present a comprehensive structural characterization of the human BRD family together with identified K<sub>ac</sub>-specific interaction sites of these essential protein recognition modules with their target sites in histones. Using available sequence databases, we identified 61 BRDs in the human proteome that are present in 46 diverse proteins. High-throughput cloning led to the establishment of 171 expression systems that yielded functional recombinant proteins. Using these reagents, we crystallized and determined the structures of 29 BRDs, including 25 structures that had not been previously published. We performed a SPOT blot analysis that covered all possible K<sub>ac</sub> sites of human histones (<xref rid="bib56" ref-type="bibr">Nady etÂ al., 2008</xref>) for 43 members of the BRD family. We identified 485 linear K<sub>ac</sub>-dependent BRD-binding motifs, and determined accurate binding affinities in solution for 81 known cellular histone marks by isothermal titration calorimetry (ITC). Furthermore, we found that BRD peptide recognition is dependent on patterns of multiple modifications rather than on a single acetylation site. This study provides a comprehensive structural comparison of this protein family interpreted in the context of a large array of histone interaction data, establishing a powerful resource for future functional studies of this family of epigenetic reader domains.</p>
    </sec>
    <sec sec-type="results" id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>The Human BRD Family</title>
        <p>Analysis of sequence databases (NCBI, UniProt, PFAM) identified 46 diverse human proteins that contain a total of 61 diverse BRDs. BRD-containing proteins are large multidomain proteins associated with chromatin remodeling, transcriptional control, methyl or acetyltransferase activity, or helicases (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A and <xref rid="tbl1" ref-type="table">Table 1</xref>). The domain organization in BRD-containing proteins is evolutionarily highly conserved, and the BRD motif is often flanked by other epigenetic reader domains. Most frequently observed combinations include the presence of plant homeodomains (PHDs) N terminal to the BRD, multiple BRDs, as well as various other domains that generally mediate protein interactions such as bromo-adjacent homology (BAH) domains (<xref rid="bib24" ref-type="bibr">Goodwin and Nicolas, 2001</xref>).</p>
        <p>Phylogenetic analysis of the BRD family outside the two central core helices was complicated by the low-sequence homology and nonconserved insertions in BRD loop regions. We therefore used three-dimensional structure-based alignments including available NMR models together with secondary structure prediction (<xref rid="bib33" ref-type="bibr">Jones, 1999</xref>) and manual curation of the aligned sequences to establish an alignment of all human BRDs (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>). The derived phylogram clustered into eight major BRD families designated by Roman numerals (IâVIII) (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B). Key references for all BRD-containing proteins are included in <xref rid="tbl1" ref-type="table">Table 1</xref>.</p>
        <p>Multiple protein interaction modules can be tightly linked to form a single stable interaction domain, or they can be connected by flexible linker sequences allowing conformational adaptation to diverse sequences motifs. An example of a tightly linked dual-domain reader is the PHD-BRD of TRIM24, in which both domains interact through a large interface that orients both peptide binding cavities to the same side of the protein (<xref rid="bib73" ref-type="bibr">Tsai etÂ al., 2010</xref>). In contrast, the two BRDs in TAF1 are free to orient independently as shown by the different domain orientations inÂ the dual-domain structure determined here and a previously published model (<xref rid="bib31" ref-type="bibr">Jacobson etÂ al., 2000</xref>) (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>C). The frequent combination of multiple interaction modules in the same protein suggests that the epigenetic reading process involves concomitant recognition of several PTMs.</p>
      </sec>
      <sec id="sec2.2">
        <title>Structural Analysis</title>
        <p>In order to establish a platform of recombinant BRDs for functional and structural studies, we subcloned all human BRDs into bacterial expression systems in frame with a cleavable N-Â (or C-) terminal His<sub>6</sub> tag. A total of 1,031 constructs resulted in the identification of 171 expression systems covering 44 BRDs that yielded stable and soluble proteins. Details of the cloned constructs are summarized in <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>, and descriptions of one representative expression system per BRD are summarized in <xref rid="mmc2" ref-type="supplementary-material">Table S2</xref>. The expressed proteins provide an excellent coverage of representative BRDs of all eight families.</p>
        <p>A total of 133 recombinant BRD constructs covering 44 unique BRDs were expressed at levels sufficient for structural studies, resulting in the determination of a total of 33 crystal structures of apo-BRDs (<xref rid="mmc4" ref-type="supplementary-material">Table S3</xref>), or BRDs in complex with acetylated peptides (<xref rid="mmc4" ref-type="supplementary-material">Table S4</xref>). Together with previously published structural information, each BRD family is represented by at least one structural model, and families I, II, and VIII are either completely or nearly completely covered (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B). All structures presented here were refined at high resolution. A summary of the crystallization conditions, data collection, and refinement statistics is compiled in <xref rid="mmc3" ref-type="supplementary-material">Table S5</xref>.</p>
        <p>Despite the low degree of overall sequence homology, all BRDs shared a conserved overall fold comprising four Î± helices (Î±<sub>Z</sub>, Î±<sub>A</sub>, Î±<sub>B</sub>, Î±<sub>C</sub>) linked by highly variable loop regions (ZA and BC loops) that form the docking site for interacting recognition motifs (<xref rid="fig1" ref-type="fig">Figures 1</xref>D and <xref rid="figs2" ref-type="fig">S2</xref>A). The C and N termini are highly diverse and may comprise additional helices that extend theÂ canonical BRD fold (e.g., the sixth BRD of PB1 has an additional C-terminal helix) or largely extended kinked helices that are present as C- or N-terminal extensions (for instance in TAF1L or ATAD2). The four helices form a deep cavity that is extended by the two loop regions (ZA and BC loops), creating a largely hydrophobic K<sub>ac</sub> binding pocket. The most notable structural difference within the BRD core fold is a hairpin insertion located between helix Î±<sub>Z</sub> and the ZA loop that is present in all family VIII members. The proximity to the K<sub>ac</sub> binding site suggests that thisÂ insert may play a role in recruitment of acetylated binding partners. Loop insertions are frequently found within the ZA loop, resulting in substantial differences in the rim region of the binding pocket. Hydrophobic residues in the ZA loop may contribute to protein instability and the low crystallization success rate observed in our work for BRDs of families VI and V. Indeed, in the recently published structure of the MLL tandem PHD-BRD module, a flexible insertion found in the MLL ZA loop was deleted in order to generate a more stable construct (<xref rid="bib77" ref-type="bibr">Wang etÂ al., 2010</xref>).</p>
        <p>In stark contrast to the conserved fold of BRDs (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>A), their surface properties are highly diverse. The electrostatic potential of the surface area around the K<sub>ac</sub> binding site ranges from highly positively to strongly negatively charged, suggesting that BRDs recognize largely different sequences (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>). Based on their surface properties, interactions with highly basic histones are not likely for BRDs with highly positive surfaces, as observed for instance for the third BRD of PB1.</p>
        <p>Structural superimposition of 33 BRD crystal structures andÂ 4Â NMR models revealed conserved motifs throughout the folded protein domain. To refer to specific sites, we chose theÂ first BRDÂ of BRD4 as a reference sequence for numbering of residues (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>A). The N-terminal helix Î±<sub>Z</sub> is highly diverse,Â but it contains three conserved hydrophobic residues oriented toward the core of the helical bundle. This conserved motif follows the generic sequence Ï<sub>1</sub>x<sub>1</sub>x<sub>2</sub>(x<sub>3</sub>)Ï<sub>2</sub>x<sub>3</sub>x<sub>4</sub>x<sub>5</sub>(x<sub>6</sub>)Ï<sub>3</sub>, where Ï<sub>i</sub> are hydrophobic residues, and x<sub>j</sub> represent any amino acid. The insertions at x<sub>3</sub> are present in the N-terminal domain of BET family members. Insertions x<sub>6</sub> are present in the C-terminal BRDs of TAF1 and TAF1L and possibly PRKCBP1 (<xref rid="figs2" ref-type="fig">Figures S2</xref>AÂ and S2B). Helix Î±<sub>Z</sub> is flanked by a diverse sequence region andÂ a Î² hairpin insert present in all family VIII BRDs (<xref rid="figs1" ref-type="fig">Figures S1</xref> and <xref rid="figs3" ref-type="fig">S3</xref>B). These diverse loop inserts are typically followed by a short helical segment in the ZA loop. The C terminus of theÂ helical segment is stabilized by a highly conserved phenylalanine (F83 in BRD4(1)) that is deeply buried by hydrophobic residues present in helix Î±<sub>C</sub>, bridging both sidesÂ of the helical bundle (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>C). The ZA loop harbors also three conserved proline residues in addition to hydrophobicÂ residues such as the conserved V87/Y97 pair that closelyÂ pack to hydrophobic residues present in Î±<sub>C</sub> stabilizing the loop conformation. A conserved tyrosine (Y97) defines the N terminus of the ZA loop helix present in all BRDs except TRIM28 and the sixth BRD of PB1, which have unusually short ZA loops that have lost this structural element (<xref rid="fig3" ref-type="fig">Figures 3</xref>A andÂ <xref rid="figs2" ref-type="fig">S2</xref>C).</p>
        <p>Helix Î±<sub>A</sub> is preceded by a PÏ<sub>1</sub>D motif (Ï<sub>1</sub> is a hydrophobic residue). The conserved aspartate caps the helix Î±<sub>A</sub> forming a hydrogen bond with a backbone amide. Also for this helix, the main sites of conservation are hydrophobic residues that contribute to the stability of the core of the structure (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>B). The loop region AB contains a highly conserved tyrosine (Y119)Â that hydrogen bonds to a conserved aspartate (D128) located in helix Î±<sub>B</sub>, presumably stabilizing the loop-helix fold. The long helix Î±<sub>B</sub> shows a conserved pattern of the sequence ÏxxDÏxxÏÏxNÏxxY/F (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>C). A conserved asparagine (N135) hydrogen bonds with the ZA loop backbone linking to this Î±<sub>B</sub> loop region that is additionally stabilized by a small hydrophobic core formed around the conserved aromatic residue (Y139) preceding the K<sub>ac</sub> docking residue (N140). An asparagine residue that anchors K<sub>ac</sub> by formation of a critical hydrogen bond initiates the BC loop. Structural comparison suggested that this asparagine can be replaced by other hydrogen bond donors, such as threonine or tyrosine side chains. In MLL, however, an aspartate occupies this position suggesting that this domain either does not bind acetylated lysine residues or has a significantly different mechanism to recognize its target sequence. Similar to helix Î±<sub>Z</sub>, the C-terminal helix Î±<sub>C</sub> exhibits little sequence conservation apart from a number of hydrophobic core residues (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>D). In summary, we have identified several highly conserved sequence motifs in BRDs that serve to stabilize the structural fold and conformation of loop regions flanking the K<sub>ac</sub> binding pocket. An overview of the sequence conservation is shown in <xref rid="figs2" ref-type="fig">FigureÂ S2</xref>D.</p>
      </sec>
      <sec id="sec2.3">
        <title>Interactions of BRDs with Histone Acetylation Sites</title>
        <p>Histone tails are hot spots of PTMs that play key roles in regulation of transcription and all aspects of chromatin biology. However, to date, no systematic study has addressed binding specificity of reader domains. Here, we used SPOT peptide arrays that cover all possible K<sub>ac</sub> sites of the human histones (H1.4, H2A, H2B, H3, and H4) in order to identify interaction sites for 33 representative BRDs. To distinguish between K<sub>ac</sub>-dependent and independent binding, we also included all corresponding unmodified peptides. In general, affinities of K<sub>ac</sub> for BRDs are low, suggesting that additional interaction domains may be required for higher affinity target-specific binding, inÂ vivo. In some cases we observed K<sub>ac</sub>-independent interaction of BRDs with nonacetylated control peptides. To date, it is not clear whether BRDs participate in K<sub>ac</sub>-independent protein interactions as it has been described for PHDs that recognize a broad variety of differently methylated, acetylated, and nonmodified peptides (<xref rid="bib41 bib59 bib73" ref-type="bibr">Lan etÂ al., 2007; Org etÂ al., 2008; Tsai etÂ al., 2010</xref>).</p>
        <p>We identified 485 interactions of BRDs to histone peptides that depend on the presence of a single K<sub>ac</sub> site (<xref rid="fig4" ref-type="fig">Figures 4</xref> and <xref rid="figs4" ref-type="fig">S4</xref>; <xref rid="mmc4" ref-type="supplementary-material">Table S6</xref>). The nuclear body protein SP140 as well as the related protein LOC93349 and PCAF showed nonspecific binding to most peptides. In contrast, the second, fourth, fifth, and sixth BRD of PB1, MLL, and TRIM28 interacted with only a few histone K<sub>ac</sub> peptides. Also, a number of promiscuous sequences were identified, such as the H2AK36 and H2BK85-containing peptides that interacted with most BRDs. To validate the detected interactions and to obtain accurate binding constants in solution, we synthesized 53 singly acetylated peptides and determined binding constants by ITC (<xref rid="mmc4" ref-type="supplementary-material">Table S7</xref>). We included also 14 peptides that did not bind to BRDs in the SPOT array. As expected these peptides did not show measurable interactions by ITC, suggesting that false negatives are not a major concern in the SPOT array study. Also in agreement with the array study, binding of 20 identified interacting peptides was confirmed by ITC experiments showing K<sub>D</sub> values between 3 andÂ â¼300Â Î¼M. However, 16 peptides that were selected based on published recognition sites did not give rise to detectable interactions in the SPOT array and still exhibited K<sub>D</sub> values between 10 and 730Â Î¼M by ITC. The detection limit of SPOT arrays is about 500Â Î¼M, but the data suggest that SPOT arrays do not detect all possible interacting motifs. Steric constraints of the immobilized peptides and potentially the lack of sufficient N- and C-terminal flanking regions are the most likely reasons for the failure to detect BRD recognition motifs in SPOT arrays. In addition, 35 (12%) of acetyl-lysine containing peptides were not recognized by acetyl-lysine specific antibodies. However, most of these peptides contained proline residues in close proximity of the K<sub>ac</sub> site, a likely reason for the failure of the antibody to recognize these sites. Other peptides showed crossreactivity with the His<sub>6</sub> antibody and have been removed from the analysis.</p>
        <p>The false negative rate was particularly high for BET family members. Recently, it was demonstrated that murine BRDT preferentially recognized diacetylated motifs, whereas most monoacetylated peptides tested did not bind tightly to mBRDT BRDs (<xref rid="bib51" ref-type="bibr">MoriniÃ¨re etÂ al., 2009</xref>). This observation prompted us to design a systematic histone H3 array in which we explored combinations of acetylated and trimethylated (K<sub>me3</sub>) lysines as well as phospho-serine/phospho-threonine (pS/pT) modifications around each acetylated lysine (<xref rid="fig5" ref-type="fig">Figures 5</xref> and <xref rid="figs5" ref-type="fig">S5</xref>).</p>
        <p>Interactions previously reported for singly acetylated lysine sites were largely confirmed. Interestingly, most of the 43 BRDs tested were highly sensitive to modifications flanking the K<sub>ac</sub> mark. For instance, BRD4(2) did not interact with H3 peptides singly acetylated on K4. In contrast, this domain showed strong interaction with diacetylated H3 (H3K4<sub>ac</sub>K9<sub>ac</sub>) but not with the same peptide acetylated at K4 but trimethylated at K9 (H3K4<sub>ac</sub>K9<sub>me3</sub>). The strongest interaction was observed using diacetylated H3K4<sub>ac</sub>K9<sub>ac</sub> in combination with phosphorylation at T3. Similarly, the BRD of FALZ showed no interaction with non- or singly acetylated K4 but interacted strongly with H3 pT3K4<sub>ac</sub>K9<sub>ac</sub>. Also, WDR9(2) and EP300 exclusively interacted with the triply modified H3 pT3K4<sub>ac</sub>K9<sub>ac</sub> peptide. The WDR9(2) interaction with H3K14<sub>ac</sub> showed strong dependence on S10 and T11 phosphorylation as well as acetylation at K18. Indeed, ITC experiments showed that the binding affinity of many BRDs was significantly increased for multiply modified peptides (<xref rid="mmc4" ref-type="supplementary-material">Tables S7 and S8</xref>). For example, the K<sub>D</sub> of CREBBP decreased from 733Â Î¼M for H3K14<sub>ac</sub> to 131Â Î¼M for H3pS10K14<sub>ac</sub>K18<sub>ac</sub> suggesting that many BRDs recognize a pattern of modifications rather than a single K<sub>ac</sub> mark.</p>
        <p>To obtain better insight into BRD recognition of multiply acetylated histone tails, we designed a systematic Î¼-SPOT array of peptide 11-mer that harbored multiple K<sub>ac</sub> sites of the N-terminal tails of histones H3 and H4 (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A). Screening against BRDs of the BET family showed that BRD4(2) interacted with most combinations of two and three acetylated lysines, whereas BRD4(1) seemed to specifically recognize multiple marks found on the H4 tail. A tetra-acetylated H4 peptide that contained the acetylation sites K5, K8, K12, and K16 bound with single-digit micromolar K<sub>D</sub> values to the first BRDs of BRD2 and BRD4, increasing affinity at least 20-fold when compared to single marks. The second BET BRDs bound to tetra-acetyl H4 peptides with about 10-fold weaker affinities, suggesting that the first BRD in BET proteins recognizes the H4 tail (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B). Recently, it was demonstrated that BRDT requires two K<sub>ac</sub> residues for high-affinity binding (<xref rid="bib51" ref-type="bibr">MoriniÃ¨re etÂ al., 2009</xref>). Our peptide binding data suggest that the BET family and several other BRDs may also recognize multiply acetylated peptides. However, our binding data cannot discriminate between simultaneous recognition of two K<sub>ac</sub> as opposed to increased avidity for a multiply modified peptide. In order to determine whether the diverse sequence and spacing of histone K<sub>ac</sub> residues can be accommodated by a single BRD, we systematically determined cocrystal structures of BRD4(1) with the diacetylated peptides H4K5<sub>ac</sub>K8<sub>ac</sub>, H4K12<sub>ac</sub>K16<sub>ac</sub>, and H4K16<sub>ac</sub>K20<sub>ac</sub>. In all cases the two acetylated lysines bound simultaneously and with identical conformations to the BRD4(1) K<sub>ac</sub> binding site (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>C). TheÂ N-terminal K<sub>ac</sub> always formed the anchoring hydrogen bond with the conserved asparagine (N140). In the N-terminal region of H4, flexible glycine residues allow variable peptide conformations with two (H4<sub>1â11</sub>K5<sub>ac</sub>K8<sub>ac</sub>; <xref rid="figs6" ref-type="fig">FigureÂ S6</xref>A) or three (H4<sub>11â21</sub>K12<sub>ac</sub>K16<sub>ac</sub>; <xref rid="figs6" ref-type="fig">FigureÂ S6</xref>B) linking residues, whereas theÂ large side chains in H4<sub>15â25</sub>K16<sub>ac</sub>K20<sub>ac</sub> (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>C) fit perfectly into surface grooves created by the ZA and BC loops.Â These structures explain the similar affinities observed for the various combinations of di- and triacetylated H4 peptides. They also suggest that the greater apparent affinity of BRD4(1) and BRD2(1) for tetra-acetylated H4 peptides is an avidity effect.Â However, not all diacetylated H4 sequences are compatible with this bidentate recognition process. The cocrystal structure of H4<sub>7â17</sub>K8<sub>ac</sub>K12<sub>ac</sub> with BRD4(1) revealed a canonical monoacetylated recognition mode (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>D), suggesting thatÂ the H4<sub>9â11</sub> linker sequence is not suitable for a simultaneousÂ recognition of the two K<sub>ac</sub> by a single BRD. Consistent with this notion, ITC experiments revealed a binding stoichiometry (N) of 0.5, indicating binding of two BRDs to the H4K8<sub>ac</sub>K12<sub>ac</sub> peptide, whereas only a single binding event with significantly increased affinity was observed for the H4K5<sub>ac</sub>K8<sub>ac</sub> peptide (<xref rid="mmc4" ref-type="supplementary-material">Table S8</xref>). A representative set of ITC data is shown in <xref rid="fig6" ref-type="fig">FigureÂ 6</xref>D.</p>
        <p>We were interested in the sequence requirements of the diacetyl-lysine BET recognition and designed a systematic peptide array in which we modulated the spacer sequence and residue properties of residues located between the two K<sub>ac</sub> binding sites (<xref rid="fig7" ref-type="fig">Figures 7</xref>A and <xref rid="figs7" ref-type="fig">S7</xref>). For the first BRDs of the BET family, a spacer of two glycine residues was optimal. However, BRD2(1) also tolerated longer linker sequences. For two-residue linkers, bulky amino acids in the first linker position were not tolerated, butÂ changes of residue properties in the second linker position did not strongly influence binding. Intriguingly, the wild-type sequence âGGâ of the H4 K5/K8 linker region seems highly optimized for interaction of the first BRD of BET family members. Binding of di-K<sub>ac</sub> marks separated by three residue spacers as found in sequences linking the H4 K8/K16 and K16/K20 required a glycine or a hydrophobic residue in the first linker position forÂ optimal binding to the first BET BRDs. Acidic residues in any linker position led to loss of interaction with H4 histone tail peptides. In contrast, the second BRDs of BET BRDs bound either weakly (BRD2), not at all (BRD3), or promiscuously (BRD4) to histone sequences and their variants present in this array. ITC data collected on the first BRD of BRD4 showedÂ a 30-fold increase in affinity between the singly acetylated peptide H4K5<sub>ac</sub> to the most optimal wild-type peptide H4K5<sub>ac</sub>K8<sub>ac</sub>. InÂ contrast, diacetylation had only a modest effect on binding affinities of the second BRD of BRD4. As reported for interactions with single acetylation sites in the case of the BRDs ofÂ BRD2 (<xref rid="bib75" ref-type="bibr">Umehara etÂ al., 2010</xref>), alanine mutants of the conserved asparagine (N140 and N443 in the first and second BRDs in BRD4) did also abolish binding of diacetylated peptides in both SPOT assays as well as in ITC (<xref rid="fig7" ref-type="fig">Figures 7</xref>B and 7C; <xref rid="mmc4" ref-type="supplementary-material">TableÂ S9</xref>).</p>
        <p>In order to address the question of whether full-length BRD4 also interacts with the identified K<sub>ac</sub> sites in the context of intact nucleosomes, we performed pull-down assays on nucleosomal preparations using Flag-tagged BRD4 and antibodies that specifically recognize K<sub>ac</sub> sites. In agreement with our peptide array studies, we identified histone interaction of BRD4 with the H4 sites K5<sub>ac</sub>, K8<sub>ac</sub>, K12<sub>ac</sub>, K16<sub>ac</sub>, and H3 K14<sub>ac</sub> (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>D). Unfortunately, no antibodies are currently available that specifically recognize diacetylated marks in histones H3 and H4. WeÂ therefore analyzed K<sub>ac</sub>-enriched tryptic digests prepared from pull-downs of salt-extracted histone using C-terminally biotinylated BRD4(1) and BRD4(2) by mass spectroscopy (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>E). We were able to detect numerous polyacetylated histone peptides associated with BRD4 BRDs; incubation with the active BRD4 inhibitor (+)-JQ1 (<xref rid="bib18" ref-type="bibr">Filippakopoulos etÂ al., 2010</xref>), but not its inactive stereoisomer (â)-JQ1, abrogated interaction with acetylated histones, indicating that the purifications were specific. Importantly, we observed that the first BRD, BRD4(1), interacted mostly with polyacetylated histone H4 peptides andÂ that the majority of peptides identified contained at least two K<sub>ac</sub> sites. These results are in good agreement with the strong increase in binding affinity and the preference for BRD4(1) for histone diacetyl marks observed in our inÂ vitro binding studies.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="sec3">
      <title>Discussion</title>
      <p>Recent developments in biotechnology and structural biology have facilitated rapid generation of structural data enabling determination of high-resolution structures of most members of certain protein families within a short time frame (<xref rid="bib3" ref-type="bibr">Barr etÂ al., 2009</xref>). The study presented here represents a comprehensive structural description of the entire human BRD family with at least one representative structural model for each branch in the BRD phylogenetic tree. Structural coverage of families I, II, and VIII is complete or nearly complete. These crystal structures enabled a detailed sequence comparison of this highly diverse domain family. Importantly, although the protein family database Pfam (<xref rid="bib19" ref-type="bibr">Finn etÂ al., 2010</xref>) extended the BRD fold from the initially predicted central helices Î±<sub>A</sub> and Î±<sub>B</sub> (<xref rid="bib27" ref-type="bibr">Haynes etÂ al., 1992</xref>) to a 110 residue motif (<xref rid="bib32" ref-type="bibr">Jeanmougin etÂ al., 1997</xref>), sequence-based tools still fail to predict correct domain boundaries for BRDs that contain long ZA and BC loop insertions. The excellent structural coverage of the BRD family enabled the identification of BRD signature motifs and family-specific secondary structure elements, such as the ZA loop helix Î±<sub>AZ</sub> and the subfamily VIII-specific Î² hairpin insert.</p>
      <sec id="sec3.1">
        <title>Probing BRD Histone Recognition by Peptide Arrays</title>
        <p>Peptide arrays offer a rapid technology for screening protein-peptide interactions. The technology was developed more than a decade ago (<xref rid="bib64" ref-type="bibr">Reineke etÂ al., 2001</xref>) and has recently been applied to study epigenetic methyl-lysine reader domain interactions with histone tails (<xref rid="bib56 bib57" ref-type="bibr">Nady etÂ al., 2008, 2011</xref>). Recent progress in array technology allows peptide densities of up to 40,000 spots per square centimeter of solid support, enabling in principle genome-wide analysis of reader domains with peptidic recognition motifs (<xref rid="bib5" ref-type="bibr">Beyer etÂ al., 2009</xref>). To date, more than 100 histone PTMs that function as recruitment platforms for chromatin proteins have been described (<xref rid="bib40" ref-type="bibr">Kouzarides, 2007</xref>). We chose, therefore, a systematic peptide array that covered all possible histone acetylation sites to characterize a representative set of BRD reader domains. However, many BRDs may interact with acetylation sites present in nonhistone proteins. In fact, we did not observe interaction with histone peptides for a number of BRDs.</p>
        <p>Recognition sites for only a few BRDs have been previously characterized, and reported substrate affinities range from the low micromolar to the millimolar K<sub>D</sub> range. Specific recognition sites in histones identified by our SPOT arrays that contained only a single K<sub>ac</sub> site per peptide had binding affinities between 3 and 350Â Î¼M, which fall into the affinity range that has been reported for other BRD-K<sub>ac</sub> interactions (<xref rid="bib71 bib83" ref-type="bibr">Shen etÂ al., 2007; Zeng etÂ al., 2008</xref>). However, comparison of binding constants determined in solution by ITC with SPOT intensity did not always correlate, suggesting that peptides linked to cellulose supports used in this study did not allow quantification of binding affinities. However, a recent study found good correlation with SPOT intensities and substrate K<sub>M</sub> values for deacetylases indicating improved correlation for proteins with enzymatic activity (<xref rid="bib72" ref-type="bibr">Smith etÂ al., 2011</xref>).</p>
      </sec>
      <sec id="sec3.2">
        <title>Many BRDs Recognize Patterns of PTMs</title>
        <p>The weak contribution of the K<sub>ac</sub> mark to the binding affinity of BRDs to their target sites makes BRD interactions particularly sensitive to changes in the environment of the K<sub>ac</sub> site. The high density of PTMs in histones and other signaling molecules results in a large number of potential combinations of marks that regulate chromatin-templated recognition processes. In this study we selected a limited but systematic set of combinations that may be present in histone H3 and comprehensively profiled this array against the human BRD family. The observed strong influence of neighboring PTMs, such as phosphorylation, on recognition of their target sites by BRDs suggests tight coupling of phosphorylation signaling with epigenetic mechanisms of regulation. Many examples of this coupling have beenÂ reported for chromatin-modifying enzymes. For instance, H3S10 phosphorylation has been shown to be functionally linked to GCN5-mediated acetylation at H3K14 (<xref rid="bib47 bib48" ref-type="bibr">Lo etÂ al., 2000, 2001</xref>), and crosstalk of the three marks, H3K9<sub>ac</sub>, H3pS10, and H4K16<sub>ac</sub>, regulates transcriptional elongation of certain genes by providing a nucleosome platform that recruits BRD4/P-TEFb (<xref rid="bib85" ref-type="bibr">Zippo etÂ al., 2009</xref>). Also, H3pS10 is a prerequisite for H3K4 trimethylation (<xref rid="bib46" ref-type="bibr">Li etÂ al., 2011</xref>), which in turn has been shown to prevent phosphorylation at H3T3 by haspin (<xref rid="bib16" ref-type="bibr">Eswaran etÂ al., 2009</xref>). These data strongly suggest that combinatorial motifs rather than single PTMs determine the cellular outcome of processes regulated by epigenetic reader domains. This hypothesis would also explain the large amount of contradictory results in studies where single marks have been assigned specific function such as transcriptional activation or silencing. Thus, the reading process of the âhistone codeâ is a sophisticated, nuanced chromatin language that recognizes combinations of marks rather than single PTMs (<xref rid="bib4" ref-type="bibr">Berger, 2007</xref>).</p>
      </sec>
      <sec id="sec3.3">
        <title>Simultaneous Binding of Multiple Acetyl-Lysines to a Single BRD</title>
        <p>Recent structural and biophysical studies demonstrated that murine BRDT requires at least two adjacent acetylation sites for tight interaction with the histone H4 tails (<xref rid="bib51" ref-type="bibr">MoriniÃ¨re etÂ al., 2009</xref>). Our SPOT array and ITC data showed that multiple K<sub>ac</sub> sites are generally required for specific recognition of the histone H4 tail by all human BET family members.</p>
        <p>We were interested if interactions of diacetyl-lysine also occur outside the BET BRD family. Using rigid docking of the H4K5<sub>ac</sub>K8<sub>ac</sub> peptide onto all available crystal structures revealed that a number of other BRDs would have an acetyl-lysine binding site architecture that would be compatible with the binding of this diacetylated peptide (data not shown).</p>
        <p>The presence of multiple reader modules in chromatin modification complexes led to the proposal that distinct epigenetic signatures are interpreted by a multivalent reading process that engages diverse binding modules (<xref rid="bib67" ref-type="bibr">Ruthenburg etÂ al., 2007</xref>). For instance, recently, the dual-reader module PHD-BRD in BPTF has been shown to specifically recognize a combination of H4K16<sub>ac</sub> and H3K4<sub>me3</sub> at the mononucleosome level (<xref rid="bib68" ref-type="bibr">Ruthenburg etÂ al., 2011</xref>). Similarly, the tandem Tudor domain of UHRF1 recognizes H3 when K9 is trimethylated, and K4 is unmodified, a histone modification state associated with heterochromatin (<xref rid="bib57" ref-type="bibr">Nady etÂ al., 2011</xref>). Combinations of PHD and BRDs are particularly frequent and are a hallmark of BRD proteins in families V and VI, and the PHD-BRD structure showed that the two reader domains form a single, stable functional unit (<xref rid="bib73" ref-type="bibr">Tsai etÂ al., 2010</xref>). The work by <xref rid="bib73" ref-type="bibr">Tsai etÂ al. (2010)</xref> also suggests that the TRIM24 PHD-BRD di-domain binds two different histone tails in opposite orientations. Similarly, our array and ITC studies on BRD4 showed that the first BRD of this protein has high affinity for the histone H4 tail, whereas the second BRD most likely recognizes multiply acetylated marks in histone H3. This would be consistent with theÂ notion that proteins that harbor multiple reader domains act as integration platforms for different chromatin proteins.</p>
      </sec>
      <sec id="sec3.4">
        <title>Epigenetic Reader Domains Are Promising Drug Targets</title>
        <p>BRDs have recently emerged as promising targets for the development of protein interaction inhibitors (<xref rid="bib10 bib18 bib28 bib58" ref-type="bibr">Chung etÂ al., 2011; Filippakopoulos etÂ al., 2010; Hewings etÂ al., 2011; Nicodeme etÂ al., 2010</xref>). The acetylation of lysine residues neutralizes theÂ charge of the primary amine. As a consequence, BRD acetyl-lysine binding sites are deep and largely hydrophobic binding pockets that represent attractive targeting sites for the development of K<sub>ac</sub> competitive inhibitors. Proteins containing epigenetic reader modules have been implicated in the development of many diseases (<xref rid="bib2 bib55 bib65" ref-type="bibr">Baker etÂ al., 2008; Muller etÂ al., 2011; Reynoird etÂ al., 2010</xref>).</p>
        <p>The recent development of potent and highly specific K<sub>ac</sub> competitive inhibitors for BET BRDs provides a compelling case for targeting these BRDs for the treatment of an extremely aggressive subtype of squamous cell carcinoma that is caused by chromosomal rearrangement of BRD3 or BRD4 with NUT (<xref rid="bib18 bib22" ref-type="bibr">Filippakopoulos etÂ al., 2010; French, 2010b</xref>). Recent data strongly suggested that targeting BET BRDs will be beneficial for many diverse cancer types due to downregulation of oncogenes such as c-Myc (<xref rid="bib12 bib13 bib50" ref-type="bibr">Dawson etÂ al., 2011; Delmore etÂ al., 2011; Mertz etÂ al., 2011</xref>). The structural data presented here provide the foundation for the rational design of selective BRD inhibitors that will be valuable tools for our understanding of the role of epigenetic reader modules in health and disease.</p>
      </sec>
    </sec>
    <sec sec-type="methods" id="sec4">
      <title>Experimental Procedures</title>
      <sec id="sec4.1">
        <title>Protein Purification</title>
        <p>BRD constructs were subcloned into pET28-derived expression vectors. AllÂ proteins were expressed as His<sub>6</sub>-tagged fusions and were purified using Ni-chelating affinity chromatography. Analytical details for construct design, protein expression, and purification are given in the <xref rid="dtbox1" ref-type="boxed-text">Extended Experimental Procedures</xref> and in <xref rid="mmc1" ref-type="supplementary-material">Tables S1</xref> and <xref rid="mmc2" ref-type="supplementary-material">S2</xref>.</p>
      </sec>
      <sec id="sec4.2">
        <title>SPOT Assays</title>
        <p>Peptides were synthesized on cellulose membranes using a MultiPep SPOT peptide arrayer (Intavis). His<sub>6</sub>-tagged BRDs were added to a final concentration of 1Â Î¼M, and blots were developed using an ECL kit (Thermo Scientific) following the manufacturer's protocol.</p>
      </sec>
      <sec id="sec4.3">
        <title>ITC</title>
        <p>Experiments were carried out on a VP-ITC or an ITC200 microcalorimeter (MicroCal, Northampton, MA, USA). In most cases a single binding site model was employed, supplied with the MicroCal Origin software package.</p>
      </sec>
      <sec id="sec4.4">
        <title>Crystallization and Structure Determination</title>
        <p>Individual proteins were crystallized at either 4Â°C or 20Â°C, and X-ray diffraction data were collected on beamlines listed in <xref rid="mmc3" ref-type="supplementary-material">Table S5</xref>. Structures were solved byÂ molecular replacement and were refined as described in detail in the <xref rid="dtbox1" ref-type="boxed-text">Extended Experimental Procedures</xref>. Crystallization conditions, data collection, refinement statistics, and PDB accession codes are listed in <xref rid="mmc4" ref-type="supplementary-material">Tables S3, S4</xref>, and <xref rid="mmc3" ref-type="supplementary-material">S5</xref>.</p>
      </sec>
      <sec id="sec4.5">
        <title>Histone Immunoprecipitation</title>
        <p>HEK293 cells were grown in DMEM with 10% fetal bovine serum (FBS) and transfected with <italic>BRD4</italic>-Flag (UniProt: O60885, residues 1â1,362, cloned in pcDNA5) vector using GeneJuice (EMD) according to the manufacturer's instructions. Nucleosome isolation protocol was based on <xref rid="bib68" ref-type="bibr">Ruthenburg etÂ al. (2011)</xref> with modification as described in the <xref rid="dtbox1" ref-type="boxed-text">Extended Experimental Procedures</xref>.</p>
      </sec>
      <sec id="sec4.6">
        <title>LC-MS/MS Analysis of Acetylated Histones and Their Quantitation</title>
        <p>HeLa cells were grown in DMEM supplemented with 10% FBS and antibiotics (penicillin-streptomycin). Histones were extracted with high salt (<xref rid="bib70" ref-type="bibr">Shechter etÂ al., 2007</xref>) and incubated with recombinant biotinylated BRDs in the presence of (+)-JQ1 or (â)-JQ1 prior to purification on Strep-Tactin Sepharose beads. After elution of bound histones using trifluoroacetic acid (TFA) and sample lyophilization, trypsin digestion was performed, and trypsin was inhibited. Acetylated peptides were purified using anti-K<sub>ac</sub> agarose beads (ImmuneChem Pharmaceuticals), and both the unbound fraction and the bound fraction (eluted in TFA) were prepared for mass spectrometry (MS). LC-MS/MS was performed using a NanoLC-Ultra 2D plus HPLC system (Eksigent) coupled to a LTQ-Orbitrap Velos (Thermo Electron) equipped with a nanoelectrospray ion source (Proxeon Biosystems). Spectra were assigned by Mascot (Matrix Science, v2.3) against the human RefSeq database (versionÂ 45). Relative quantitation of acetylated peptides was achieved with Proteome Discoverer 1.2 (Thermo Electron). The efficiency of purification with each BRD was monitored by analyzing the fraction unbound to anti-K<sub>ac</sub>; specificity was ascertained by analyzing the samples incubated with the inhibitor (+)-JQ1.</p>
        <p>
          <boxed-text id="dtbox1">
            <label>Extended Experimental Procedures</label>
            <sec id="tdbox1sec1">
              <title>Cloning</title>
              <p>cDNA encoding human BRD containing proteins were obtained from different sources. Most of them were synthesized (Genscript) for codon optimization, some were provided by the MGC collection, the IMAGE collection or from commercial sources. The obtained cDNA sequences were used as templates to amplify BRD regions employing the Polymerase Chain Reaction (PCR) in the presence of Platinum Pfx DNA polymerase (Invitrogen, UK). All relevant details are listed in <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>. PCR products were purified (QIAquick PCR Purification Kit, QIAGEN Ltd. UK) and further subcloned into pET28 derived expression vectors, pNIC28-Bsa4 (gi|124015065) or pNIC-CTHF (gi|124015079), using ligation independent cloning (<xref rid="bib116" ref-type="bibr">Stols etÂ al., 2002</xref>). Constructs were transformed into competent Mach1 cells (Invitrogen, UK) to yield the final plasmid DNA and were verified by sequencing.</p>
            </sec>
            <sec id="tdbox1sec2">
              <title>Protein Expression and Purification for Biophysical Characterization</title>
              <p>Constructs were transformed into competent BL21 (DE3) cells (Invitrogen) or into BL21 (DE3)-R3-pRARE2 cells (phage-resistant derivative with a pRARE plasmid encoding rare codon tRNAs). Cells were grown at 37Â°C either in Luria-Bertani medium (LB-broth, Merck) or in Terrific Broth (Merck) from overnight cultures. Protein expression was induced overnight with 0.1Â mM isopropyl-Î²-D-thiogalactopyranoside (IPTG) at 18Â°C at an OD<sub>600</sub> nm of 0.9 or 3.0 respectively. Cultures were harvested by centrifugation (8,700Â x <italic>g</italic> for 15Â min at 4Â°C) on a Beckman Coulter Avanti J-20 XP centrifuge, and then re-suspended in lysis buffer (50Â mM HEPES, pH 7.5 at 20Â°C, 500Â mM NaCl, 5Â mM Imidazole, 5% glycerol and 0.5Â mM tris(2-carboxyethyl)phosphine (TCEP) in the presence ofÂ 1:200 (v/v) Protease Inhibitor Cocktail III (Calbiochem). Cells were lysed at 4Â°C using an EmulsiFlex-C5 high pressure homogenizerÂ (Avestin - Mannheim, Germany) and the DNA was removed by precipitation on ice for 30Â min with 0.15% (v/v) of PEI (Polyethyleneimine). Lysates were cleared by centrifugation (16,000 x <italic>g</italic> for 1h at 4Â°C, JA 25.50 rotor, on a Beckman Coulter Avanti J-20 XP centrifuge) and were applied to a Nickel affinity column (nickel nitrilotriacetic acid (Ni-NTA) resin, QIAGEN Ltd., 5Â ml, equilibrated with 20Â ml lysis buffer). Columns were washed once with 30Â ml of lysis buffer then twice with 10Â ml of lysis buffer containing 30Â mM Imidazole. Proteins were eluted using a step elution of imidazole in lysis buffer (50, 100, 150, 2Â Ã 250Â mM Imidazole). AllÂ fractions were collected and monitored by SDS-polyacrylamide gel electrophoresis (Bio-Rad Criterion Precast Gels, 4%â12% Bis-Tris, 1.0Â mm, from Bio-Rad, CA. Gel run conditions: 180 V, 400 mA, 55Â min in XT MES buffer). The eluted proteins were treated overnight at 4Â°C with TEV (Tobacco Etch Virus) protease to remove the hexa-histidine expression tag and were further purified by size exclusion chromatography on Superdex 75 16/60 HiLoad gel filtration columns (GE/Amersham Biosciences) on ÃktaPrime plus systems (GE/Amersham Biosciences). Proteins in 10Â mM HEPES, 500Â mM NaCl and 5% glycerol were concentrated to 10Â mg/ml with a AmiconÂ® Ultra (MILLIPORE) concentrators employing 10Â kDa cut-offs (10 MWCO), flash frozen in liquid nitrogen and stored at â80Â°C. Protein concentration was estimated using a NanoDrop ND-1000 spectrophotometer (also see <xref rid="mmc2" ref-type="supplementary-material">Table S2</xref>).</p>
            </sec>
            <sec id="tdbox1sec3">
              <title>Protein Expression and Purification for Spot Assays</title>
              <p>Soluble BRD constructs were expressed in LB media (5Â Ã 50Â ml) in the presence of 50Â Î¼g/ml kanamycin. Cell growth was allowed at 37Â°C to an optical density of about 0.5 (OD<sub>600nm</sub>). Protein expression was induced by 1Â mM IPTG, overnight, at 18Â°C. Cells were harvested by centrifugation at 4,000Â Ã <italic>g</italic> for 15Â min at 4Â°C and re-suspended in 4Â ml of binding buffer (50Â mM HEPES pH7.5 at 20Â°C; 500Â mM NaCl; 5% glycerol, 5Â mM Imidazole) complemented with 0.5Â mM TCEP and 1:200 (v/v) Protease Inhibitor Cocktail III (Calbiochem). Cells were disrupted with an ultrasonic processor (SONICS Vibra-Cell, amplitude 60, 10Â s ON, 10Â s OFF, for 2Â min). Lysates were cleared by centrifugation and were applied to Ni-NTA columns (QIAGEN Ltd., 2Â ml, equilibrated with 20Â ml lysis buffer). Columns were washed once with 30Â ml of lysis buffer then twice with 10Â ml of the same buffer containing 30Â mM Imidazole. Proteins were eluted using a step elution of imidazole in lysis buffer (50, 100, 150, 2Â Ã 250Â mM Imidazole). All fractions were collected and monitored by SDS-polyacrylamide gel electrophoresis. Fractions containing the recombinant proteins were pooled and concentrated using AmiconÂ® Ultra (MILLIPORE) concentrators (10 MWCO) to a final volume of 1Â ml before being loaded on NAP-10 column (GE-Healthcare) in order to exchange the buffer to 25Â mM HEPES (pH 7.5 at 20Â°C), 150Â mM NaCl and 5% glycerol. Samples were flash frozen in liquid nitrogen and stored at â80Â°C until used (<xref rid="mmc2" ref-type="supplementary-material">Table S2</xref>).</p>
            </sec>
            <sec id="tdbox1sec4">
              <title>SPOT Assays</title>
              <p>Three different types of SPOT membrane were utilized in order to probe preferences of BRD recognition sites: the first array contained peptides from all four core histones (H2A, H2B, H3 and H4) covering all possible lysine acetylation sites, with peptide sizes ranging from 10 to 14 amino acids. The second array contained short peptides (11 residues) from human histone 3 exploiting possible posttranslational modifications around each acetyl-lysine epitope, including phosphorylation (on serine and threonine residues), acetylation (on lysine residues) and trimethylation (on lysine residues). The third array covered all possible lysine acetylation sites found on the four core human histones, as well as peptides containing multiple adjacent acetyl-lysine epitopes, employing a microSPOT (Î¼SPOT) technology using a smaller foot-print.</p>
            </sec>
            <sec id="tdbox1sec5">
              <title>Membranes Synthesis</title>
              <p>Peptides for the first two arrays were synthesized directly on cellulose membranes (Intavis) using a MultiPep SPOT peptide arrayer (Intavis) and commercially available standard (Intavis) or modified (Bachem) L-amino acid precursors as previously described (<xref rid="bib56" ref-type="bibr">Nady etÂ al., 2008</xref>). The quality of the synthesized array was evaluated as follows: i) immune reactive peptides were identified by incubation of the membrane with an anti-His antibody in the absence of any His<sub>6</sub>-tagged BRD. 8 peptides were recognized by this antibody and were excluded from the analysis.</p>
              <p>In all cases a general monoclonal primary antibody against acetylated lysine (#9681, Cell Signaling Technology) was used to probe the proper incorporation of acetylated lysine on each membrane, using the protocol provided by the manufacturer for Western blotting. Phosphorylation was probed using a primary antibody against phosphorylated Ser10 (ab47297, Abcam) and Thr11 (ab5168, Abcam), employing an anti-rabbit HRP fragment secondary antibody (Amersham Biosciences).</p>
            </sec>
            <sec id="tdbox1sec6">
              <title>Protein-Peptide Interaction Assay</title>
              <p>Membranes were washed 3Â Ã 5Â min with PBST (3.2Â mM Na<sub>2</sub>HPO<sub>4</sub>, 0.5Â mM KH<sub>2</sub>PO<sub>4</sub>, 1.3Â mM KCl, 135Â mM NaCl and 0.1% Tween 20, pH 7.4) and were subsequently blocked with 5% milk in PBST overnight at 4Â°C in order to minimize nonspecific binding of the proteins to the membranes. After 2 washes with PBST (5Â min each) followed by a single wash with PBS (3.2Â mM Na<sub>2</sub>HPO<sub>4</sub>, 0.5Â mM KH<sub>2</sub>PO<sub>4</sub>, 1.3Â mM KCl, 135Â mM NaCl pH 7.4) for 5Â min, his<sub>6</sub> tagged BRD proteins were added to a final concentration of 1Â Î¼M and the membranes were incubated over night at 4Â°C in PBS. Each membrane was washed 3 times in PBST, blocked for 1Â hr with 10% milk in PBST, and washed again 3Â Ã 5Â min with PBST. HPR-conjugated anti-His-tag antibodies (Novagen #71841) were added in 5% milk/PBST solution at a dilution of 1:2000. After 1Â hr incubation, membranes were washed 3Â Ã 20Â min in PBST. The assay was developed with an ECL kit (Pierce ECL Western Blotting substrate, Thermo Scientific) following the manufacturer's protocol. Chem-illuminescence was detected with an Image reader (Fujifilm LAS-4000 ver.2.0) with an incremental exposure time of 5Â min for a total of 80Â min. Intensities of the resulting spots were quantified with the Kodak 1D ver.3.6.2 Scientific Imaging System. All experiments were performed at room temperature.</p>
            </sec>
            <sec id="tdbox1sec7">
              <title>Membrane Stripping</title>
              <p>Membranes were washed 3Â Ã 10Â min in water, 2Â Ã 30Â min in stripping buffer A (6Â M Guanidinium HCl, 1% Triton X-100) followed by an overnight incubation with Stripping Buffer A and Talon Beads at room temperature. The next day each membrane was washed twiceÂ with Stripping Buffer B (500Â mM Imidazole, 500Â mM NaCl, 20mM TRIS-HCl, pH 7.5) for 30Â min each, followed by a series of washes with deionized and distilled water (ddH<sub>2</sub>O) at room temperature and at 60Â°C. Finally, a series of washes was performed, 10Â min each with ddH<sub>2</sub>O, 10% TFA (trifluoroacetic acid), ddH<sub>2</sub>O, 20% EtOH, 50% EtOH and 95% EtOH. Membrane were dried overnight and stored for extended periods of time at â20Â°C until they were re-used.</p>
            </sec>
            <sec id="tdbox1sec8">
              <title>Crystallization and Structure Determination</title>
              <p>Individual proteins were crystallized in sitting drops at either 4Â°C or 20Â°C. Crystals were cryo-protected, flash frozen and X-ray diffraction data were collected at 100 K on beam lines X10SA at the Swiss Light Source (SLS), at Diamond (beam lines I02, I03, I04, I04.1), or at a Rigaku FRE Superbright home source. Diffraction images were indexed, and integrated using MOSFLM (<xref rid="bib103" ref-type="bibr">Leslie and Powell, 2007</xref>), HKL2000 or XDS (<xref rid="bib100" ref-type="bibr">Kabsch, 2010b</xref>) and data were scaled using SCALA (<xref rid="bib93" ref-type="bibr">Evans, 2007</xref>), SCALEPACK (<xref rid="bib111" ref-type="bibr">Otwinowski and Minor, 1997</xref>), or XSCALE (<xref rid="bib99" ref-type="bibr">Kabsch, 2010a</xref>), respectively. Structures were solved by molecular replacement using PHASER (<xref rid="bib106" ref-type="bibr">McCoy etÂ al., 2005</xref>) and were refined against maximum likelihood targets using REFMAC (<xref rid="bib109" ref-type="bibr">Murshudov etÂ al., 1997</xref>). Iterative rounds of refinement were interspersed with manual rebuilding in COOT (<xref rid="bib92" ref-type="bibr">Emsley and Cowtan, 2004</xref>). Thermal motions were analyzed using TLSMD (<xref rid="bib112" ref-type="bibr">Painter and Merritt, 2006</xref>) and hydrogen atoms were included in late refinement cycles. Crystallization conditions, data collection and refinement statistics, PDB accession codes are compiled in <xref rid="mmc3" ref-type="supplementary-material">Table S5</xref>.</p>
            </sec>
            <sec id="tdbox1sec9">
              <title>Structure-Based Alignment and Sequence Analysis</title>
              <p>Multiple sequence/structural alignments were carried out using STRAP (<xref rid="bib95" ref-type="bibr">Gille and FrÃ¶mmel, 2001</xref>) and ICM Pro (MolSoft LLC version 3.7-2c) (<xref rid="bib87" ref-type="bibr">Abagyan etÂ al., 1994</xref>) and were further manually edited (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>). In the absence of an X-Ray or NMR structure model the PFAM boundaries for each BRD were extended using PSIPRED (version 2) (<xref rid="bib33" ref-type="bibr">Jones, 1999</xref>) for secondary structure prediction and the secondary structure elements were further used to guide the STRAP/ICM alignment. A phylogenetic tree of the resulting structure based alignment was generated using the ClustalW2 program (<xref rid="bib102" ref-type="bibr">Larkin etÂ al., 2007</xref>) and is given in <xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B. Sequence conservations were visualized using the WebLogo (<xref rid="bib91" ref-type="bibr">Crooks etÂ al., 2004</xref>) online web server.</p>
            </sec>
            <sec id="tdbox1sec10">
              <title>Isothermal Titration Calorimetry</title>
              <p>Experiments were carried out on a VP-ITC microcalorimeter or an ITC200 (MicroCal, LLC Northampton, MA). All experiments were performed at 10 or 15Â°C in 50Â mM HEPES pH 7.5, 150Â mM NaCl. All titrations were conducted using an initial injection of 2Â Î¼l followed by 29 identical injections of 8Â Î¼l (VP-ITC) or 0.3Â Î¼l followed by identical injections of 1Â Î¼l (ITC200). The dilution heats were measured on separate experiments and were subtracted from the titration data. Thermodynamic parameters were calculated using Î<italic>G</italic>Â = Î<italic>H</italic> - TÎ<italic>S</italic>Â = -RTln<italic>K</italic><sub>B</sub>, where Î<italic>G</italic>, Î<italic>H</italic> and Î<italic>S</italic> are the changes in free energy, enthalpy and entropy of binding respectively. In most cases a single binding site model was employed, supplied with the MicroCal Origin software package. Multiple binding events were also confirmed with the software package SEDPHAT (<xref rid="bib96" ref-type="bibr">Houtman etÂ al., 2007</xref>). Binding constants and thermodynamic parameters are given in <xref rid="mmc4" ref-type="supplementary-material">Tables S7</xref> (Single K<sub>ac</sub> marks), <xref rid="mmc4" ref-type="supplementary-material">S8</xref> (multiple marks) and <xref rid="mmc4" ref-type="supplementary-material">S9</xref> (linker sequences).</p>
            </sec>
            <sec id="tdbox1sec11">
              <title>Histone Immunoprecipitation</title>
              <p>HEK293 cells were grown in DMEM with 10% FBS and transfected with Brd4-Flag (UniProt: O60885, residues 1-1362, cloned in pcDNA5) vector using GeneJuice (EMD) according to the manufacturer's instructions. The transfected cells were treated with 500Â nM (+)-JQ1 or (-)-JQ1 (<xref rid="bib18" ref-type="bibr">Filippakopoulos etÂ al., 2010</xref>) for 16Â hr and cells collected by scraping. Nucleosome isolation protocol was based on Ruthenburg and co-workers (<xref rid="bib68" ref-type="bibr">Ruthenburg etÂ al., 2011</xref>) with modification at the end of the nuclease treatment. Briefly the cells were washed in buffer A (10Â mM HEPES pH 7.9, 10Â mM KCl, 1.5Â mM MgCl<sub>2</sub>, 340Â mM sucrose, 10% (v/v) glycerol, protease inhibitors (Roche) TSA 1Â Î¼g/ml, beta-mercaptoethanol 5Â mM. The cell pellet was resuspended in buffer A with 0.1% Triton x-100 and incubated on ice for 10Â min. The nuclei were pelleted, washed twice with buffer A and resuspended in buffer A to nucleic acid concentration of 1.2Â Î¼g/Î¼l measured as previously described (<xref rid="bib89" ref-type="bibr">Brand etÂ al., 2008</xref>). CaCl<sub>2</sub> was added to 2Â mM, followed by the micrococcal nuclease (Worthington) (1Â U/50Â Î¼g DNA) and the reaction incubated at 37Â°C for 10Â min. The reaction stopped adding 4Â mM EGTA on ice. To facilitate the release of digested nucleosomes, NaCl was added to final concentrations of 200Â mM and reactions spun down at 13,000Â rpm for 5Â min. The soluble nucleosomes in the supernatant were collected and diluted (1:5) in the IP buffer (100Â mM KCl 5% glycerol, 10Â mM TRIS-HCl pH 8.0, 10Â mg/ml BSA, protease inhibitors, 1Â Î¼g/ml TSA, beta-mercaptoethanol 5Â mM). Anti-Flag M2 antibody (Sigma) or normal mouse IgG (Abcam) and protein G Dynabeads (Invitrogen) were added and incubated at 4Â°C overnight. The reactions were washed 5 times in the IP buffer and eluted with 100Â mM TRIS-HCl pH 8.0, 150Â mM NaCl, 2Â mM EDTA, 5Â mM DTT, 1% Triton, 3% SDS 15Â mM beta-mercaptoethanol. The immunoprecipitated proteins were run on Tris-Bis PAGE (Invitrogen) and transferred to nitrocellulose membranes (Pall) that were probed with the following antibodies: H4K5<sub>ac</sub> (Abcam 61236), H4K12<sub>ac</sub> (Upstate 07-595), H4 (Abcam 7311), H3K9<sub>ac</sub> (Abcam 12179), H4K16<sub>ac</sub> (Active Motif 39167), H4K18<sub>ac</sub> (Cell Signaling Technology 2594) and secondary HRP conjugated antibodies (Cell Signaling Technology).</p>
            </sec>
            <sec id="tdbox1sec12">
              <title>Preparation of Asynchronous and M Phase HeLa Cells</title>
              <p>HeLa cells were grown in DMEM supplemented with 10% fetal bovine serum and antibiotics (Penicillin-Streptomycin cocktail). In order to generate cells arrested in M phase, cells at â¼50% confluency were first treated with 2Â mM thymidine for 24 h; the media was then removed, the cells washed with 1X PBS, and fresh media added for three hours to allow release from the thymidine block. Nocodazole (100Â ng/ml) was then added for 16Â hr to arrest cells in M phase. The cells were then harvested by âmitotic shake-offâ to harvest rounded mitotic cells which were then washed with cold PBS and frozen as a dry pellet at â80Â°C.</p>
            </sec>
            <sec id="tdbox1sec13">
              <title>High-Salt Extraction of Histones</title>
              <p>Histones were extracted from asynchronous or M phase cells using high-salt as previously described (<xref rid="bib70" ref-type="bibr">Shechter etÂ al., 2007</xref>) with minor modifications. Briefly, frozen cell pellets from 20Â Ã 15Â cm plates of HeLa cells (corresponding to approximately 4Â Ã 10<sup>8</sup> cells) were resuspended in 10Â ml of cold extraction buffer (10Â mM HEPES-NaOH pH 8.0, 10Â mM KCl, 1.5Â mM MgCl<sub>2</sub>, 0.34Â M sucrose, 10% glycerol, 0.1Â mM PMSF, 10Â mM sodium butyrate) with 0.2% NP-40 and incubated on ice for 10Â min with occasional mixing. Samples were then centrifuged (6,500 x <italic>g</italic>, 5Â min at 4Â°C) and the supernatant discarded. An additional 10Â ml of cold extraction buffer without NP-40 was used to resuspend the pellet, and the mixture was centrifuged (6,500 x <italic>g</italic>, 5Â min at 4Â°C). The supernatant was completely removed and the pellet resuspended in 10Â ml of no-salt buffer (3Â mM EDTA, 0.2Â mM EGTA), vortexed intermittently for 2Â min and further incubated at 4Â°C on a nutator for 30Â min. The samples were then centrifuged (6,500 x <italic>g</italic>, 5Â min at 4Â°C) and the supernatant discarded. Histones were extracted by vortexing the pellet in 10Â ml of high-salt solubilization buffer (50Â mM TRIS-HCl pH 8.0, 2.5Â M NaCl, 0.5% NP-40) for 2Â min, followed by incubation at 4Â°C on a nutator for 30Â min. DNA was pelleted by centrifugation (16,000 x <italic>g</italic>, 10Â min at 4Â°C) and the supernatant containing histones transferred to a fresh tube. Three buffer exchanges were performed with a spin filter device of 5,000Â Da molecular weight cut-off to reduce salt concentration before storing at â80Â°C until further use.</p>
            </sec>
            <sec id="tdbox1sec14">
              <title>Biotin-Tagged Bromodomain Affinity Purification</title>
              <p>500Â Î¼g of salt-extracted histones from asynchronous or M phase HeLa cells were mixed with 50Â Î¼g of recombinant biotinylated BRD4(1) or BRD4(2) and incubated at 4Â°C on a nutator for 60Â min in the presence of 1Â Î¼M (+)-JQ1 or 1Â Î¼M (-)-JQ1. Samples were transferred to a fresh tube containing 30Â Î¼l of streptactin sepharose beads (IBA BioTAGnology) and incubated for 60Â min at 4Â°C on a nutator. The beads were then washed five times with 1Â ml of wash buffer (50Â mM HEPES-NaOH pH 8.0, 500Â mM KCl, 2Â mM EDTA, 0.1% NP-40, 10% glycerol) and two times with 1Â ml of no-salt wash buffer (20Â mM TRIS-HCl pH 8.0, 2Â mM CaCl<sub>2</sub>). Bound histones were eluted by incubating the beads in 1Â ml of 0.5% Trifluoroacetic acid (TFA) at 4Â°C on a nutator. The supernatants were transferred to fresh tubes and then evaporated to dryness and stored at â80Â°C.</p>
            </sec>
            <sec id="tdbox1sec15">
              <title>Protein Digestion and Acetylated Peptide Purification</title>
              <p>Dried sample were resuspended in 100Â Î¼l of 20Â mM TRIS-HCl pH 8.0, and 1Â Î¼g of trypsin (Sigma-Aldrich; Singles) was added to each sample. Samples were incubated overnight at 37Â°C with agitation, and supplemented with an extra 0.5Â Î¼g of trypsin before another incubation of 4Â hr. The samples were then boiled for 10Â min to inhibit trypsin activity and subsequently let to cool down to room temperature for approximately 15Â min. Samples were then diluted to 400Â Î¼l with peptide wash buffer solution (50Â mM MOPS pHÂ 7.2, 10Â mM NaPO<sub>4</sub>, 50Â mM NaCl) and incubated with 30Â Î¼l of anti-acetyl-lysine agarose beads (ImmuneChem Pharmaceuticals Inc.) overnight at 4Â°C. The next morning, the beads were collected by gentle centrifugation and the supernatant (unbound fraction) transferred to a fresh tube for subsequent analysis by mass spectrometry. The beads were washed once with 1Â ml of peptide wash buffer solution and once with 1Â ml of no-salt wash buffer (20Â mM TRIS-HCl pH 8.0, 2Â mM CaCl<sub>2</sub>). Peptides were eluted by incubating the beads with 1Â ml of 0.5% TFA for 30Â min at 4Â°C and then transferred to a fresh tube before being evaporated to dryness.</p>
            </sec>
            <sec id="tdbox1sec16">
              <title>LC-MS/MS Analysis of Acetylated Histones and Their Quantitation</title>
              <p>Dried peptides were dissolved in 5% formic acid and analyzed by LC-MS/MS using a NanoLC-Ultra 2D plus HPLC system (Eksigent, Dublin, USA) coupled to a LTQ-Orbitrap Velos (Thermo Electron, Bremen, Germany) equipped with a nanoelectrospray ion source (Proxeon Biosystems, Odense, Denmark). The LTQ-Orbitrap Velos instrument under Xcalibur 2.0 was operated in the data dependent mode to automatically switch between MS and up to 10 subsequent MS/MS acquisition. Raw MS and MS/MS spectra were processed using Prohits (<xref rid="bib105" ref-type="bibr">Liu etÂ al., 2010</xref>). Peptides and proteins were identified using the Mascot software (Matrix Science, London, UK) and the human RefSeq database (version 45, released on February 2nd 2010, containing 34,604 sequences). Mass tolerance of 7Â ppm in MS mode and 0.6Â Da in MS/MS mode with trypsin specificity were used, and 4 missed cleavage sites were allowed. No fixed modification was selected, but N-acetyl protein, N-pyroglutamine, oxidized methionine, acetylation of lysine and phosphorylation of serine, threonine and tyrosine were searched as variable modifications. Relative quantitation of acetylated peptides using MS spectra was achieved with Proteome Discoverer 1.2 (Thermo Electron, Bremen, Germany). The peak area for acetylated peptides co-purifying with BRD4(1) or BRD4(2) were calculated first by summing the areas under the curve for a given acetylated peptide in the asynchronous or nocodazole-arrested cells (for a given bromodomain), then by computing the area of all acetylated peptides associated with either bromodomain. The relative peak intensity of each acetylated peptide was then determined by expressing (in percent) the ratio of the area under the peak of a given peptide peak over the total area under the peak of all peptides. The efficiency of purification with each bromodomain was monitored by analyzing the fraction unbound to the anti-acetyl lysine beads; specificity in the interaction was ascertained by analyzing by quantitative MS each of the samples incubated with the inhibitors (-)-JQ1 and (+)-JQ1.</p>
            </sec>
          </boxed-text>
        </p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bai</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Jurynec</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Akie</surname>
              <given-names>T.E.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>LeBlanc</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sessa</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>DiBiase</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>TIF1gamma controls erythroid cell fate by regulating transcription elongation</article-title>
          <source>Cell</source>
          <volume>142</volume>
          <year>2010</year>
          <fpage>133</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">20603019</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>G.G.</given-names>
            </name>
          </person-group>
          <article-title>PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks</article-title>
          <source>Mutat. Res.</source>
          <volume>647</volume>
          <year>2008</year>
          <fpage>3</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">18682256</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barr</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Ugochukwu</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>O.N.</given-names>
            </name>
            <name>
              <surname>Filippakopoulos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Alfano</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Savitsky</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Burgess-Brown</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>MÃ¼ller</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Knapp</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Large-scale structural analysis of the classical human protein tyrosine phosphatome</article-title>
          <source>Cell</source>
          <volume>136</volume>
          <year>2009</year>
          <fpage>352</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">19167335</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berger</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>The complex language of chromatin regulation during transcription</article-title>
          <source>Nature</source>
          <volume>447</volume>
          <year>2007</year>
          <fpage>407</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="pmid">17522673</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beyer</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Block</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>KÃ¶nig</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nesterov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Felgenhauer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Schirwitz</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Leibe</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bischoff</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Breitling</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Stadler</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>A novel combinatorial approach to high-density peptide arrays</article-title>
          <source>Methods Mol. Biol.</source>
          <volume>570</volume>
          <year>2009</year>
          <fpage>309</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="pmid">19649602</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bloch</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Nakajima</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gulick</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chiche</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Orth</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>de La Monte</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Bloch</surname>
              <given-names>K.D.</given-names>
            </name>
          </person-group>
          <article-title>Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>20</volume>
          <year>2000</year>
          <fpage>6138</fpage>
          <lpage>6146</lpage>
          <pub-id pub-id-type="pmid">10913195</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cai</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tomomori-Sato</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sorokina</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Parmely</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Conaway</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Conaway</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex</article-title>
          <source>J. Biol. Chem.</source>
          <volume>278</volume>
          <year>2003</year>
          <fpage>42733</fpage>
          <lpage>42736</lpage>
          <pub-id pub-id-type="pmid">12963728</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>CavellÃ¡n</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Asp</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Percipalle</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Farrants</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>16264</fpage>
          <lpage>16271</lpage>
          <pub-id pub-id-type="pmid">16603771</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choudhary</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gnad</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Rehman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Walther</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>J.V.</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Lysine acetylation targets protein complexes and co-regulates major cellular functions</article-title>
          <source>Science</source>
          <volume>325</volume>
          <year>2009</year>
          <fpage>834</fpage>
          <lpage>840</lpage>
          <pub-id pub-id-type="pmid">19608861</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Coste</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Mirguet</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Wilde</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gosmini</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Delves</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Magny</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Woodward</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Discovery and characterization of small molecule inhibitors of the BET family bromodomains</article-title>
          <source>J. Med. Chem.</source>
          <volume>54</volume>
          <year>2011</year>
          <fpage>3827</fpage>
          <lpage>3838</lpage>
          <pub-id pub-id-type="pmid">21568322</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>CirÃ³</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Prosperini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Quarto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Grazini</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Walfridsson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>McBlane</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Nucifero</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Pacchiana</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Capra</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Helin</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors</article-title>
          <source>Cancer Res.</source>
          <volume>69</volume>
          <year>2009</year>
          <fpage>8491</fpage>
          <lpage>8498</lpage>
          <pub-id pub-id-type="pmid">19843847</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawson</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Prinjha</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Dittmann</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Giotopoulos</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bantscheff</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>W.I.</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Hopf</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Savitski</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</article-title>
          <source>Nature</source>
          <volume>478</volume>
          <year>2011</year>
          <fpage>529</fpage>
          <lpage>533</lpage>
          <pub-id pub-id-type="pmid">21964340</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delmore</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Issa</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Lemieux</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Rahl</surname>
              <given-names>P.B.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Kastritis</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Gilpatrick</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Paranal</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>BET bromodomain inhibition as a therapeutic strategy to target c-Myc</article-title>
          <source>Cell</source>
          <volume>146</volume>
          <year>2011</year>
          <fpage>904</fpage>
          <lpage>917</lpage>
          <pub-id pub-id-type="pmid">21889194</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dhalluin</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Aggarwal</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Structure and ligand of a histone acetyltransferase bromodomain</article-title>
          <source>Nature</source>
          <volume>399</volume>
          <year>1999</year>
          <fpage>491</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="pmid">10365964</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Milne</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Tackett</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>E.R.</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wysocka</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Chait</surname>
              <given-names>B.T.</given-names>
            </name>
            <name>
              <surname>Hess</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Roeder</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF</article-title>
          <source>Cell</source>
          <volume>121</volume>
          <year>2005</year>
          <fpage>873</fpage>
          <lpage>885</lpage>
          <pub-id pub-id-type="pmid">15960975</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eswaran</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Patnaik</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Filippakopoulos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Knapp</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Structure and functional characterization of the atypical human kinase haspin</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>106</volume>
          <year>2009</year>
          <fpage>20198</fpage>
          <lpage>20203</lpage>
          <pub-id pub-id-type="pmid">19918057</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fairbridge</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Dawe</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Niri</surname>
              <given-names>F.H.</given-names>
            </name>
            <name>
              <surname>Kooistra</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>King-Jones</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>McDermid</surname>
              <given-names>H.E.</given-names>
            </name>
          </person-group>
          <article-title>Cecr2 mutations causing exencephaly trigger misregulation of mesenchymal/ectodermal transcription factors</article-title>
          <source>Birth Defects Res. A Clin. Mol. Teratol.</source>
          <volume>88</volume>
          <year>2010</year>
          <fpage>619</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="pmid">20589882</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Filippakopoulos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Qi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Picaud</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>W.B.</given-names>
            </name>
            <name>
              <surname>Fedorov</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Morse</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Keates</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hickman</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Felletar</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Selective inhibition of BET bromodomains</article-title>
          <source>Nature</source>
          <volume>468</volume>
          <year>2010</year>
          <fpage>1067</fpage>
          <lpage>1073</lpage>
          <pub-id pub-id-type="pmid">20871596</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finn</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Mistry</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tate</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Coggill</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Heger</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pollington</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Gavin</surname>
              <given-names>O.L.</given-names>
            </name>
            <name>
              <surname>Gunasekaran</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ceric</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Forslund</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>The Pfam protein families database</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>38</volume>
          <issue>Database issue</issue>
          <year>2010</year>
          <fpage>D211</fpage>
          <lpage>D222</lpage>
          <pub-id pub-id-type="pmid">19920124</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fossey</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Pendleton</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Bowden</surname>
              <given-names>D.W.</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of PRKCBP1, a candidate RACK-like protein</article-title>
          <source>Mamm. Genome</source>
          <volume>11</volume>
          <year>2000</year>
          <fpage>919</fpage>
          <lpage>925</lpage>
          <pub-id pub-id-type="pmid">11003709</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>French</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Demystified molecular pathology of NUT midline carcinomas</article-title>
          <source>J. Clin. Pathol.</source>
          <volume>63</volume>
          <year>2010</year>
          <fpage>492</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="pmid">18552174</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>French</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>NUT midline carcinoma</article-title>
          <source>Cancer Genet. Cytogenet.</source>
          <volume>203</volume>
          <year>2010</year>
          <fpage>16</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">20951314</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>French</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Aster</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Kubonishi</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kroll</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Dal Cin</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>S.O.</given-names>
            </name>
            <name>
              <surname>Perez-Atayde</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)</article-title>
          <source>Am. J. Pathol.</source>
          <volume>159</volume>
          <year>2001</year>
          <fpage>1987</fpage>
          <lpage>1992</lpage>
          <pub-id pub-id-type="pmid">11733348</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goodwin</surname>
              <given-names>G.H.</given-names>
            </name>
            <name>
              <surname>Nicolas</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>The BAH domain, polybromo and the RSC chromatin remodelling complex</article-title>
          <source>Gene</source>
          <volume>268</volume>
          <year>2001</year>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">11368894</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gregory</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Vakoc</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Rozovskaia</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Canaani</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Blobel</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>8466</fpage>
          <lpage>8479</lpage>
          <pub-id pub-id-type="pmid">17923682</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harikrishnan</surname>
              <given-names>K.N.</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>M.Z.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Pal</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bassal</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Brasacchio</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Sif</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>El-Osta</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing</article-title>
          <source>Nat. Genet.</source>
          <volume>37</volume>
          <year>2005</year>
          <fpage>254</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">15696166</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haynes</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Dollard</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Winston</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Trowsdale</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dawid</surname>
              <given-names>I.B.</given-names>
            </name>
          </person-group>
          <article-title>The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins</article-title>
          <source>Nucleic Acids Res.</source>
          <volume>20</volume>
          <year>1992</year>
          <fpage>2603</fpage>
          <pub-id pub-id-type="pmid">1350857</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hewings</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Philpott</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fedorov</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Uttarkar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Filippakopoulos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Picaud</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vuppusetty</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Marsden</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Knapp</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands</article-title>
          <source>J. Med. Chem.</source>
          <volume>54</volume>
          <year>2011</year>
          <fpage>6761</fpage>
          <lpage>6770</lpage>
          <pub-id pub-id-type="pmid">21851057</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rambaldi</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Daniels</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Featherstone</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Expression of the Wdr9 gene and protein products during mouse development</article-title>
          <source>Dev. Dyn.</source>
          <volume>227</volume>
          <year>2003</year>
          <fpage>608</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="pmid">12889071</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails</article-title>
          <source>BMC Struct. Biol.</source>
          <volume>7</volume>
          <year>2007</year>
          <fpage>57</fpage>
          <pub-id pub-id-type="pmid">17848202</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobson</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Ladurner</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Tjian</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Structure and function of a human TAFII250 double bromodomain module</article-title>
          <source>Science</source>
          <volume>288</volume>
          <year>2000</year>
          <fpage>1422</fpage>
          <lpage>1425</lpage>
          <pub-id pub-id-type="pmid">10827952</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jeanmougin</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Wurtz</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Le Douarin</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Chambon</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Losson</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The bromodomain revisited</article-title>
          <source>Trends Biochem. Sci.</source>
          <volume>22</volume>
          <year>1997</year>
          <fpage>151</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">9175470</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>D.T.</given-names>
            </name>
          </person-group>
          <article-title>Protein secondary structure prediction based on position-specific scoring matrices</article-title>
          <source>J. Mol. Biol.</source>
          <volume>292</volume>
          <year>1999</year>
          <fpage>195</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">10493868</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Hamana</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Nezu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shimane</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A novel family of bromodomain genes</article-title>
          <source>Genomics</source>
          <volume>63</volume>
          <year>2000</year>
          <fpage>40</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">10662543</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaeser</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Aslanian</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>M.Q.</given-names>
            </name>
            <name>
              <surname>Yates</surname>
              <given-names>J.R.</given-names>
              <suffix>III</suffix>
            </name>
            <name>
              <surname>Emerson</surname>
              <given-names>B.M.</given-names>
            </name>
          </person-group>
          <article-title>BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells</article-title>
          <source>J. Biol. Chem.</source>
          <volume>283</volume>
          <year>2008</year>
          <fpage>32254</fpage>
          <lpage>32263</lpage>
          <pub-id pub-id-type="pmid">18809673</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalkhoven</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>CBP and p300: HATs for different occasions</article-title>
          <source>Biochem. Pharmacol.</source>
          <volume>68</volume>
          <year>2004</year>
          <fpage>1145</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="pmid">15313412</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanno</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kanno</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Lenardo</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Ozato</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Selective recognition of acetylated histones by bromodomain proteins visualized in living cells</article-title>
          <source>Mol. Cell</source>
          <volume>13</volume>
          <year>2004</year>
          <fpage>33</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">14731392</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khetchoumian</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Teletin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mark</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lerouge</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>CerviÃ±o</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Oulad-Abdelghani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Chambon</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Losson</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>TIF1delta, a novel HP1-interacting member of the transcriptional intermediary factor 1 (TIF1) family expressed by elongating spermatids</article-title>
          <source>J. Biol. Chem.</source>
          <volume>279</volume>
          <year>2004</year>
          <fpage>48329</fpage>
          <lpage>48341</lpage>
          <pub-id pub-id-type="pmid">15322135</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kouzarides</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Acetylation: a regulatory modification to rival phosphorylation?</article-title>
          <source>EMBO J.</source>
          <volume>19</volume>
          <year>2000</year>
          <fpage>1176</fpage>
          <lpage>1179</lpage>
          <pub-id pub-id-type="pmid">10716917</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kouzarides</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Chromatin modifications and their function</article-title>
          <source>Cell</source>
          <volume>128</volume>
          <year>2007</year>
          <fpage>693</fpage>
          <lpage>705</lpage>
          <pub-id pub-id-type="pmid">17320507</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lan</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>De Cegli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Alpatov</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Horton</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Gozani</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Recognition of unmethylated histone H3Â lysine 4 links BHC80 to LSD1-mediated gene repression</article-title>
          <source>Nature</source>
          <volume>448</volume>
          <year>2007</year>
          <fpage>718</fpage>
          <lpage>722</lpage>
          <pub-id pub-id-type="pmid">17687328</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lane</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Chabner</surname>
              <given-names>B.A.</given-names>
            </name>
          </person-group>
          <article-title>Histone deacetylase inhibitors in cancer therapy</article-title>
          <source>J. Clin. Oncol.</source>
          <volume>27</volume>
          <year>2009</year>
          <fpage>5459</fpage>
          <lpage>5468</lpage>
          <pub-id pub-id-type="pmid">19826124</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laue</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Daujat</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Crump</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Plaster</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Roehl</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Kimmel</surname>
              <given-names>C.B.</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>M.</given-names>
            </name>
            <collab>TÃ¼bingen 2000 Screen Consortium</collab>
          </person-group>
          <article-title>The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity</article-title>
          <source>Development</source>
          <volume>135</volume>
          <year>2008</year>
          <fpage>1935</fpage>
          <lpage>1946</lpage>
          <pub-id pub-id-type="pmid">18469222</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LeRoy</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rickards</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Flint</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription</article-title>
          <source>Mol. Cell</source>
          <volume>30</volume>
          <year>2008</year>
          <fpage>51</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">18406326</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ilin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Wysocka</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF</article-title>
          <source>Nature</source>
          <volume>442</volume>
          <year>2006</year>
          <fpage>91</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">16728978</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gui</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Shang</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>The histone modifications governing TFF1 transcription mediated by estrogen receptor</article-title>
          <source>J. Biol. Chem.</source>
          <volume>286</volume>
          <year>2011</year>
          <fpage>13925</fpage>
          <lpage>13936</lpage>
          <pub-id pub-id-type="pmid">21378170</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lo</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Trievel</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Rojas</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Duggan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Marmorstein</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylation of serine 10 in histone H3 is functionally linked inÂ vitro and inÂ vivo to Gcn5-mediated acetylation at lysine 14</article-title>
          <source>Mol. Cell</source>
          <volume>5</volume>
          <year>2000</year>
          <fpage>917</fpage>
          <lpage>926</lpage>
          <pub-id pub-id-type="pmid">10911986</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lo</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Duggan</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Emre</surname>
              <given-names>N.C.</given-names>
            </name>
            <name>
              <surname>Belotserkovskya</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Shiekhattar</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>Snf1âa histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription</article-title>
          <source>Science</source>
          <volume>293</volume>
          <year>2001</year>
          <fpage>1142</fpage>
          <lpage>1146</lpage>
          <pub-id pub-id-type="pmid">11498592</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masselink</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bernards</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR</article-title>
          <source>Oncogene</source>
          <volume>19</volume>
          <year>2000</year>
          <fpage>1538</fpage>
          <lpage>1546</lpage>
          <pub-id pub-id-type="pmid">10734313</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mertz</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Conery</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Sandy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Balasubramanian</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mele</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Bergeron</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sims</surname>
              <given-names>R.J.</given-names>
              <suffix>III</suffix>
            </name>
          </person-group>
          <article-title>Targeting MYC dependence in cancer by inhibiting BET bromodomains</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>108</volume>
          <year>2011</year>
          <fpage>16669</fpage>
          <lpage>16674</lpage>
          <pub-id pub-id-type="pmid">21949397</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MoriniÃ¨re</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rousseaux</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Steuerwald</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Soler-LÃ³pez</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Curtet</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vitte</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Govin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gaucher</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sadoul</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Cooperative binding of two acetylation marks on a histone tail by a single bromodomain</article-title>
          <source>Nature</source>
          <volume>461</volume>
          <year>2009</year>
          <fpage>664</fpage>
          <lpage>668</lpage>
          <pub-id pub-id-type="pmid">19794495</pub-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MÃ¼ller</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kuttenkeuler</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gesellchen</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Zeidler</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Boutros</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Identification of JAK/STAT signalling components by genome-wide RNA interference</article-title>
          <source>Nature</source>
          <volume>436</volume>
          <year>2005</year>
          <fpage>871</fpage>
          <lpage>875</lpage>
          <pub-id pub-id-type="pmid">16094372</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muller</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Filippakopoulos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Knapp</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Bromodomains as therapeutic targets</article-title>
          <source>Expert Rev. Mol. Med.</source>
          <volume>13</volume>
          <year>2011</year>
          <fpage>e29</fpage>
          <pub-id pub-id-type="pmid">21933453</pub-id>
        </element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nady</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kareta</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>ChÃ©din</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Arrowsmith</surname>
              <given-names>C.H.</given-names>
            </name>
          </person-group>
          <article-title>A SPOT on the chromatin landscape? Histone peptide arrays as a tool for epigenetic research</article-title>
          <source>Trends Biochem. Sci.</source>
          <volume>33</volume>
          <year>2008</year>
          <fpage>305</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="pmid">18538573</pub-id>
        </element-citation>
      </ref>
      <ref id="bib57">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nady</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lemak</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Avvakumov</surname>
              <given-names>G.V.</given-names>
            </name>
            <name>
              <surname>Kareta</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Achour</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Allali-Hassani</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zuo</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Recognition of multivalent histone states associated with heterochromatin by UHRF1</article-title>
          <source>J. Biol. Chem.</source>
          <volume>286</volume>
          <year>2011</year>
          <fpage>24300</fpage>
          <lpage>24311</lpage>
          <pub-id pub-id-type="pmid">21489993</pub-id>
        </element-citation>
      </ref>
      <ref id="bib58">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicodeme</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Jeffrey</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Beinke</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dewell</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>C.W.</given-names>
            </name>
            <name>
              <surname>Chandwani</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Marazzi</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Coste</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Suppression of inflammation by a synthetic histone mimic</article-title>
          <source>Nature</source>
          <volume>468</volume>
          <year>2010</year>
          <fpage>1119</fpage>
          <lpage>1123</lpage>
          <pub-id pub-id-type="pmid">21068722</pub-id>
        </element-citation>
      </ref>
      <ref id="bib59">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Org</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chignola</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>HetÃ©nyi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gaetani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rebane</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Liiv</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Maran</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Mollica</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bottomley</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Musco</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression</article-title>
          <source>EMBO Rep.</source>
          <volume>9</volume>
          <year>2008</year>
          <fpage>370</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="pmid">18292755</pub-id>
        </element-citation>
      </ref>
      <ref id="bib60">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Owen</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Ornaghi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Ballario</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Neuhaus</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Filetici</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Travers</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p</article-title>
          <source>EMBO J.</source>
          <volume>19</volume>
          <year>2000</year>
          <fpage>6141</fpage>
          <lpage>6149</lpage>
          <pub-id pub-id-type="pmid">11080160</pub-id>
        </element-citation>
      </ref>
      <ref id="bib61">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Podcheko</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Northcott</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bikopoulos</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bommareddi</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Kushner</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Farhang-Fallah</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rozakis-Adcock</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a WD40 repeat-containing isoform of PHIP as a novel regulator of beta-cell growth and survival</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>27</volume>
          <year>2007</year>
          <fpage>6484</fpage>
          <lpage>6496</lpage>
          <pub-id pub-id-type="pmid">17636024</pub-id>
        </element-citation>
      </ref>
      <ref id="bib62">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Racki</surname>
              <given-names>L.R.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Naber</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Partensky</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Acevedo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Purcell</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Cooke</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Narlikar</surname>
              <given-names>G.J.</given-names>
            </name>
          </person-group>
          <article-title>The chromatin remodeller ACF acts as a dimeric motor to space nucleosomes</article-title>
          <source>Nature</source>
          <volume>462</volume>
          <year>2009</year>
          <fpage>1016</fpage>
          <lpage>1021</lpage>
          <pub-id pub-id-type="pmid">20033039</pub-id>
        </element-citation>
      </ref>
      <ref id="bib63">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rada-Iglesias</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bajpai</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Swigut</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Brugmann</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Flynn</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Wysocka</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>A unique chromatin signature uncovers early developmental enhancers in humans</article-title>
          <source>Nature</source>
          <volume>470</volume>
          <year>2011</year>
          <fpage>279</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="pmid">21160473</pub-id>
        </element-citation>
      </ref>
      <ref id="bib64">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reineke</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Volkmer-Engert</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Schneider-Mergener</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Applications of peptide arrays prepared by the SPOT-technology</article-title>
          <source>Curr. Opin. Biotechnol.</source>
          <volume>12</volume>
          <year>2001</year>
          <fpage>59</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">11167074</pub-id>
        </element-citation>
      </ref>
      <ref id="bib65">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reynoird</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Delvecchio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sadoul</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Meyers</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Caron</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rousseaux</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains</article-title>
          <source>EMBO J.</source>
          <volume>29</volume>
          <year>2010</year>
          <fpage>2943</fpage>
          <lpage>2952</lpage>
          <pub-id pub-id-type="pmid">20676058</pub-id>
        </element-citation>
      </ref>
      <ref id="bib66">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rowe</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Jakobsson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mesnard</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Rougemont</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Reynard</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aktas</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maillard</surname>
              <given-names>P.V.</given-names>
            </name>
            <name>
              <surname>Layard-Liesching</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Verp</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Marquis</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>KAP1 controls endogenous retroviruses in embryonic stem cells</article-title>
          <source>Nature</source>
          <volume>463</volume>
          <year>2010</year>
          <fpage>237</fpage>
          <lpage>240</lpage>
          <pub-id pub-id-type="pmid">20075919</pub-id>
        </element-citation>
      </ref>
      <ref id="bib67">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruthenburg</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>Multivalent engagement of chromatin modifications by linked binding modules</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>8</volume>
          <year>2007</year>
          <fpage>983</fpage>
          <lpage>994</lpage>
          <pub-id pub-id-type="pmid">18037899</pub-id>
        </element-citation>
      </ref>
      <ref id="bib68">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruthenburg</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Milne</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Dewell</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>McGinty</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Yuen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ueberheide</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Dou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Muir</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions</article-title>
          <source>Cell</source>
          <volume>145</volume>
          <year>2011</year>
          <fpage>692</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="pmid">21596426</pub-id>
        </element-citation>
      </ref>
      <ref id="bib69">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shahbazian</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Grunstein</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Functions of site-specific histone acetylation and deacetylation</article-title>
          <source>Annu. Rev. Biochem.</source>
          <volume>76</volume>
          <year>2007</year>
          <fpage>75</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">17362198</pub-id>
        </element-citation>
      </ref>
      <ref id="bib70">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shechter</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dormann</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Hake</surname>
              <given-names>S.B.</given-names>
            </name>
          </person-group>
          <article-title>Extraction, purification and analysis of histones</article-title>
          <source>Nat. Protoc.</source>
          <volume>2</volume>
          <year>2007</year>
          <fpage>1445</fpage>
          <lpage>1457</lpage>
          <pub-id pub-id-type="pmid">17545981</pub-id>
        </element-citation>
      </ref>
      <ref id="bib71">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>W.Q.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Y.Y.</given-names>
            </name>
          </person-group>
          <article-title>Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails</article-title>
          <source>Biochemistry</source>
          <volume>46</volume>
          <year>2007</year>
          <fpage>2100</fpage>
          <lpage>2110</lpage>
          <pub-id pub-id-type="pmid">17274598</pub-id>
        </element-citation>
      </ref>
      <ref id="bib72">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>B.C.</given-names>
            </name>
            <name>
              <surname>Settles</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Hallows</surname>
              <given-names>W.C.</given-names>
            </name>
            <name>
              <surname>Craven</surname>
              <given-names>M.W.</given-names>
            </name>
            <name>
              <surname>Denu</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>SIRT3 substrate specificity determined by peptide arrays and machine learning</article-title>
          <source>ACS Chem. Biol.</source>
          <volume>6</volume>
          <year>2011</year>
          <fpage>146</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="pmid">20945913</pub-id>
        </element-citation>
      </ref>
      <ref id="bib73">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>W.W.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Yiu</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Akdemir</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Winter</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Schwarzer</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Plunkett</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>TRIM24 links a non-canonical histone signature to breast cancer</article-title>
          <source>Nature</source>
          <volume>468</volume>
          <year>2010</year>
          <fpage>927</fpage>
          <lpage>932</lpage>
          <pub-id pub-id-type="pmid">21164480</pub-id>
        </element-citation>
      </ref>
      <ref id="bib74">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ullah</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pelletier</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Degerny</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tahmasebi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cayrou</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Doyon</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Goh</surname>
              <given-names>S.L.</given-names>
            </name>
          </person-group>
          <article-title>Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>28</volume>
          <year>2008</year>
          <fpage>6828</fpage>
          <lpage>6843</lpage>
          <pub-id pub-id-type="pmid">18794358</pub-id>
        </element-citation>
      </ref>
      <ref id="bib75">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Umehara</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ozato</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Padmanabhan</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yokoyama</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain</article-title>
          <source>J. Biol. Chem.</source>
          <volume>285</volume>
          <year>2010</year>
          <fpage>7610</fpage>
          <lpage>7618</lpage>
          <pub-id pub-id-type="pmid">20048151</pub-id>
        </element-citation>
      </ref>
      <ref id="bib76">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Functional substitution for TAF(II)250 by a retroposed homolog that is expressed in human spermatogenesis</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>11</volume>
          <year>2002</year>
          <fpage>2341</fpage>
          <lpage>2346</lpage>
          <pub-id pub-id-type="pmid">12217962</pub-id>
        </element-citation>
      </ref>
      <ref id="bib77">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Milne</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>G.G.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Allis</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4meÂ readout to CyP33 and HDAC-mediated repression</article-title>
          <source>Cell</source>
          <volume>141</volume>
          <year>2010</year>
          <fpage>1183</fpage>
          <lpage>1194</lpage>
          <pub-id pub-id-type="pmid">20541251</pub-id>
        </element-citation>
      </ref>
      <ref id="bib78">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wassarman</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>TAF(II)250: a transcription toolbox</article-title>
          <source>J.Â Cell Sci.</source>
          <volume>114</volume>
          <year>2001</year>
          <fpage>2895</fpage>
          <lpage>2902</lpage>
          <pub-id pub-id-type="pmid">11686293</pub-id>
        </element-citation>
      </ref>
      <ref id="bib79">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xue</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Canman</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Nie</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>G.T.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Salmon</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>97</volume>
          <year>2000</year>
          <fpage>13015</fpage>
          <lpage>13020</lpage>
          <pub-id pub-id-type="pmid">11078522</pub-id>
        </element-citation>
      </ref>
      <ref id="bib80">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>X.J.</given-names>
            </name>
            <name>
              <surname>Ogryzko</surname>
              <given-names>V.V.</given-names>
            </name>
            <name>
              <surname>Nishikawa</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Nakatani</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A</article-title>
          <source>Nature</source>
          <volume>382</volume>
          <year>1996</year>
          <fpage>319</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">8684459</pub-id>
        </element-citation>
      </ref>
      <ref id="bib81">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Q.</given-names>
            </name>
          </person-group>
          <article-title>Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression</article-title>
          <source>Mol. Cell. Biol.</source>
          <volume>28</volume>
          <year>2008</year>
          <fpage>967</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="pmid">18039861</pub-id>
        </element-citation>
      </ref>
      <ref id="bib82">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yordy</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Moussa</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Pei</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Chaussabel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>D.K.</given-names>
            </name>
          </person-group>
          <article-title>SP100 inhibits ETS1 activity in primary endothelial cells</article-title>
          <source>Oncogene</source>
          <volume>24</volume>
          <year>2005</year>
          <fpage>916</fpage>
          <lpage>931</lpage>
          <pub-id pub-id-type="pmid">15592518</pub-id>
        </element-citation>
      </ref>
      <ref id="bib83">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeng</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Gerona-Navarro</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Moshkina</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>M.M.</given-names>
            </name>
          </person-group>
          <article-title>Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300</article-title>
          <source>Structure</source>
          <volume>16</volume>
          <year>2008</year>
          <fpage>643</fpage>
          <lpage>652</lpage>
          <pub-id pub-id-type="pmid">18400184</pub-id>
        </element-citation>
      </ref>
      <ref id="bib84">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Akhtar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Grummt</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Reversible acetylation of the chromatin remodelling complex NoRC is requiredÂ for non-coding RNA-dependent silencing</article-title>
          <source>Nat. Cell Biol.</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>1010</fpage>
          <lpage>1016</lpage>
          <pub-id pub-id-type="pmid">19578370</pub-id>
        </element-citation>
      </ref>
      <ref id="bib85">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zippo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Serafini</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rocchigiani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pennacchini</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Krepelova</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Oliviero</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation</article-title>
          <source>Cell</source>
          <volume>138</volume>
          <year>2009</year>
          <fpage>1122</fpage>
          <lpage>1136</lpage>
          <pub-id pub-id-type="pmid">19766566</pub-id>
        </element-citation>
      </ref>
      <ref id="bib86">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zong</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tucker</surname>
              <given-names>P.W.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies</article-title>
          <source>EMBO J.</source>
          <volume>19</volume>
          <year>2000</year>
          <fpage>4123</fpage>
          <lpage>4133</lpage>
          <pub-id pub-id-type="pmid">10921892</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ref-list>
      <title>Supplemental References</title>
      <ref id="bib87">
        <mixed-citation publication-type="other">Abagyan, R., Totrov, M., and Kuznetsov, D. (1994). ICMâa new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. <italic>15</italic>, 488â506.</mixed-citation>
      </ref>
      <ref id="bib88">
        <mixed-citation publication-type="other">Akai, Y., Adachi, N., Hayashi, Y., Eitoku, M., Sano, N., Natsume, R., Kudo, N., Tanokura, M., Senda, T., and Horikoshi, M. (2010). Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction. Proc. Natl. Acad. Sci. USA <italic>107</italic>, 8153â8158.</mixed-citation>
      </ref>
      <ref id="bib89">
        <mixed-citation publication-type="other">Brand, M., Rampalli, S., Chaturvedi, C.P., and Dilworth, F.J. (2008). Analysis of epigenetic modifications of chromatin at specific gene loci by native chromatin immunoprecipitation of nucleosomes isolated using hydroxyapatite chromatography. Nat. Protoc. <italic>3</italic>, 398â409.</mixed-citation>
      </ref>
      <ref id="bib90">
        <mixed-citation publication-type="other">Charlop-Powers, Z., Zeng, L., Zhang, Q., and Zhou, M.M. (2010). Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2. Cell Res. <italic>20</italic>, 529â538.</mixed-citation>
      </ref>
      <ref id="bib91">
        <mixed-citation publication-type="other">Crooks, G.E., Hon, G., Chandonia, J.M., and Brenner, S.E. (2004). WebLogo: a sequence logo generator. Genome Res. <italic>14</italic>, 1188â1190.</mixed-citation>
      </ref>
      <ref id="bib92">
        <mixed-citation publication-type="other">Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. <italic>60</italic>, 2126â2132.</mixed-citation>
      </ref>
      <ref id="bib93">
        <mixed-citation publication-type="other">Evans, P. (2007). SCALA - scale together multiple observations of reflections (Cambridge: MRC Laboratory of Molecular Biology).</mixed-citation>
      </ref>
      <ref id="bib94">
        <mixed-citation publication-type="other">Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W.B., Fedorov, O., Morse, E.M., Keates, T., Hickman, T.T., Felletar, I., etÂ al. (2010). Selective inhibition of BET bromodomains. Nature <italic>468</italic>, 1067â1073.</mixed-citation>
      </ref>
      <ref id="bib95">
        <mixed-citation publication-type="other">Gille, C., and FrÃ¶mmel, C. (2001). STRAP: editor for STRuctural Alignments of Proteins. Bioinformatics <italic>17</italic>, 377â378.</mixed-citation>
      </ref>
      <ref id="bib96">
        <mixed-citation publication-type="other">Houtman, J.C., Brown, P.H., Bowden, B., Yamaguchi, H., Appella, E., Samelson, L.E., and Schuck, P. (2007). Studying multisite binary and ternary protein interactions by global analysis of isothermal titration calorimetry data in SEDPHAT: application to adaptor protein complexes in cell signaling. Protein Sci. <italic>16</italic>, 30â42.</mixed-citation>
      </ref>
      <ref id="bib97">
        <mixed-citation publication-type="other">Jacobson, R.H., Ladurner, A.G., King, D.S., and Tjian, R. (2000). Structure and function of a human TAFII250 double bromodomain module. Science <italic>288</italic>, 1422â1425.</mixed-citation>
      </ref>
      <ref id="bib98">
        <mixed-citation publication-type="other">Jones, D.T. (1999). Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. <italic>292</italic>, 195â202.</mixed-citation>
      </ref>
      <ref id="bib99">
        <mixed-citation publication-type="other">Kabsch, W. (2010a). Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D Biol. Crystallogr. <italic>66</italic>, 133â144.</mixed-citation>
      </ref>
      <ref id="bib100">
        <mixed-citation publication-type="other">Kabsch, W. (2010b). Xds. Acta Crystallogr. D Biol. Crystallogr. <italic>66</italic>, 125â132.</mixed-citation>
      </ref>
      <ref id="bib101">
        <mixed-citation publication-type="other">Klosi, E., Saro, D., and Spaller, M.R. (2007). Bivalent peptides as PDZ domain ligands. Bioorg. Med. Chem. Lett. <italic>17</italic>, 6147â6150.</mixed-citation>
      </ref>
      <ref id="bib102">
        <mixed-citation publication-type="other">Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., McWilliam, H., Valentin, F., Wallace, I.M., Wilm, A., Lopez, R., etÂ al. (2007). Clustal W and Clustal X version 2.0. Bioinformatics <italic>23</italic>, 2947â2948.</mixed-citation>
      </ref>
      <ref id="bib103">
        <mixed-citation publication-type="other">Leslie, A.G.W., and Powell, H. (2007). MOSFLM (Cambridge: MRC Laboratory of Molecular Biology).</mixed-citation>
      </ref>
      <ref id="bib104">
        <mixed-citation publication-type="other">Li, H., Ilin, S., Wang, W., Duncan, E.M., Wysocka, J., Allis, C.D., and Patel, D.J. (2006). Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature <italic>442</italic>, 91â95.</mixed-citation>
      </ref>
      <ref id="bib105">
        <mixed-citation publication-type="other">Liu, G., Zhang, J., Larsen, B., Stark, C., Breitkreutz, A., Lin, Z.Y., Breitkreutz, B.J., Ding, Y., Colwill, K., Pasculescu, A., etÂ al. (2010). ProHits: integrated software for mass spectrometry-based interaction proteomics. Nat. Biotechnol. <italic>28</italic>, 1015â1017.</mixed-citation>
      </ref>
      <ref id="bib106">
        <mixed-citation publication-type="other">McCoy, A.J., Grosse-Kunstleve, R.W., Storoni, L.C., and Read, R.J. (2005). Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. <italic>61</italic>, 458â464.</mixed-citation>
      </ref>
      <ref id="bib107">
        <mixed-citation publication-type="other">Mujtaba, S., He, Y., Zeng, L., Farooq, A., Carlson, J.E., Ott, M., Verdin, E., and Zhou, M.M. (2002). Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell <italic>9</italic>, 575â586.</mixed-citation>
      </ref>
      <ref id="bib108">
        <mixed-citation publication-type="other">Mujtaba, S., He, Y., Zeng, L., Yan, S., Plotnikova, O., Sachchidanand, Sanchez, R., Zeleznik-Le, N.J., Ronai, Z., and Zhou, M.M. (2004). Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol. Cell <italic>13</italic>, 251â263.</mixed-citation>
      </ref>
      <ref id="bib109">
        <mixed-citation publication-type="other">Murshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. <italic>53</italic>, 240â255.</mixed-citation>
      </ref>
      <ref id="bib110">
        <mixed-citation publication-type="other">Nady, N., Min, J., Kareta, M.S., ChÃ©din, F., and Arrowsmith, C.H. (2008). A SPOT on the chromatin landscape? Histone peptide arrays as a tool for epigenetic research. Trends Biochem. Sci. <italic>33</italic>, 305â313.</mixed-citation>
      </ref>
      <ref id="bib111">
        <mixed-citation publication-type="other">Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. In Macromolecular Crystallography, Part A, C.W. Carter, Jr., and R. Sweet, eds. (San Diego: Academic Press Inc), pp. 307â326.</mixed-citation>
      </ref>
      <ref id="bib112">
        <mixed-citation publication-type="other">Painter, J., and Merritt, E.A. (2006). Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. <italic>62</italic>, 439â450.</mixed-citation>
      </ref>
      <ref id="bib113">
        <mixed-citation publication-type="other">Ruthenburg, A.J., Li, H., Milne, T.A., Dewell, S., McGinty, R.K., Yuen, M., Ueberheide, B., Dou, Y., Muir, T.W., Patel, D.J., and Allis, C.D. (2011). Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell <italic>145</italic>, 692â706.</mixed-citation>
      </ref>
      <ref id="bib114">
        <mixed-citation publication-type="other">Shechter, D., Dormann, H.L., Allis, C.D., and Hake, S.B. (2007). Extraction, purification and analysis of histones. Nat. Protoc. <italic>2</italic>, 1445â1457.</mixed-citation>
      </ref>
      <ref id="bib115">
        <mixed-citation publication-type="other">Singh, M., Popowicz, G.M., Krajewski, M., and Holak, T.A. (2007). Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex. ChemBioChem <italic>8</italic>, 1308â1316.</mixed-citation>
      </ref>
      <ref id="bib116">
        <mixed-citation publication-type="other">Stols, L., Gu, M.Y., Dieckman, L., Raffen, R., Collart, F.R., and Donnelly, M.I. (2002). A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. Protein Expr. Purif. <italic>25</italic>, 8â15.</mixed-citation>
      </ref>
      <ref id="bib117">
        <mixed-citation publication-type="other">Sun, H., Liu, J., Zhang, J., Shen, W., Huang, H., Xu, C., Dai, H., Wu, J., and Shi, Y. (2007). Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4. Biochem. Biophys. Res. Commun. <italic>358</italic>, 435â441.</mixed-citation>
      </ref>
      <ref id="bib118">
        <mixed-citation publication-type="other">Umehara, T., Nakamura, Y., Jang, M.K., Nakano, K., Tanaka, A., Ozato, K., Padmanabhan, B., and Yokoyama, S. (2010). Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem. <italic>285</italic>, 7610â7618.</mixed-citation>
      </ref>
      <ref id="bib119">
        <mixed-citation publication-type="other">Tsai, W.W., Wang, Z., Yiu, T.T., Akdemir, K.C., Xia, W., Winter, S., Tsai, C.Y., Shi, X., Schwarzer, D., Plunkett, W., etÂ al. (2010). TRIM24 links a non-canonical histone signature to breast cancer. Nature <italic>468</italic>, 927â932.</mixed-citation>
      </ref>
      <ref id="bib120">
        <mixed-citation publication-type="other">Vollmuth, F., and Geyer, M. (2010). Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. Angew. Chem. Int. Ed. Engl. <italic>49</italic>, 6768â6772.</mixed-citation>
      </ref>
      <ref id="bib121">
        <mixed-citation publication-type="other">Wang, Z., Song, J., Milne, T.A., Wang, G.G., Li, H., Allis, C.D., and Patel, D.J. (2010). Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell <italic>141</italic>, 1183â1194.</mixed-citation>
      </ref>
      <ref id="bib122">
        <mixed-citation publication-type="other">Xi, Q., Wang, Z., Zaromytidou, A.I., Zhang, X.H., Chow-Tsang, L.F., Liu, J.X., Kim, H., Barlas, A., Manova-Todorova, K., Kaartinen, V., etÂ al. (2011). A poised chromatin platform for TGF-Î² access to master regulators. Cell <italic>147</italic>, 1511â1524.</mixed-citation>
      </ref>
      <ref id="bib123">
        <mixed-citation publication-type="other">Zeng, L., Zhang, Q., Gerona-Navarro, G., Moshkina, N., and Zhou, M.M. (2008). Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure <italic>16</italic>, 643â652.</mixed-citation>
      </ref>
    </ref-list>
    <sec id="app1">
      <title>Accession Numbers</title>
      <p>The models and structure factors of the reported bromodomain proteins haveÂ been deposited in the Protein Data Bank with the PDB accession codesÂ <ext-link ext-link-type="uri" xlink:href="pdb:2NXB">2NXB</ext-link> (BRD3(1)), <ext-link ext-link-type="uri" xlink:href="pdb:2OO1">2OO1</ext-link> (BRD3(2)), <ext-link ext-link-type="uri" xlink:href="pdb:2OSS">2OSS</ext-link> (BRD4(1)), <ext-link ext-link-type="uri" xlink:href="pdb:2OUO">2OUO</ext-link> (BRD4(2)), <ext-link ext-link-type="uri" xlink:href="pdb:2RFJ">2RFJ</ext-link> (BRDT(1)), <ext-link ext-link-type="uri" xlink:href="pdb:3HME">3HME</ext-link> (BRD9), <ext-link ext-link-type="uri" xlink:href="pdb:3D7C">3D7C</ext-link> (GCN5L2), <ext-link ext-link-type="uri" xlink:href="pdb:3DAI">3DAI</ext-link> (ATAD2), <ext-link ext-link-type="uri" xlink:href="pdb:3G0L">3G0L</ext-link> (BAZ2B), <ext-link ext-link-type="uri" xlink:href="pdb:3GG3">3GG3</ext-link> (PCAF), <ext-link ext-link-type="uri" xlink:href="pdb:3DWY">3DWY</ext-link> (CREBBP), <ext-link ext-link-type="uri" xlink:href="pdb:3UV2">3UV2</ext-link> (FALZ), <ext-link ext-link-type="uri" xlink:href="pdb:3IU5">3IU5</ext-link> (PB1(1)), <ext-link ext-link-type="uri" xlink:href="pdb:3HMF">3HMF</ext-link> (PB1(2)), <ext-link ext-link-type="uri" xlink:href="pdb:3K2J">3K2J</ext-link> (PB1(3)), <ext-link ext-link-type="uri" xlink:href="pdb:3TLP">3TLP</ext-link> (PB1(4)), <ext-link ext-link-type="uri" xlink:href="pdb:3G0J">3G0J</ext-link> (PB1(5)), <ext-link ext-link-type="uri" xlink:href="pdb:3IU6">3IU6</ext-link> (PB1(6)), <ext-link ext-link-type="uri" xlink:href="pdb:3I3J">3I3J</ext-link> (EP300), <ext-link ext-link-type="uri" xlink:href="pdb:3HMH">3HMH</ext-link> (TAF1L(2)), <ext-link ext-link-type="uri" xlink:href="pdb:3UV4">3UV4</ext-link> (TAF1(2)), <ext-link ext-link-type="uri" xlink:href="pdb:3LXJ">3LXJ</ext-link> (KIAA1240), <ext-link ext-link-type="uri" xlink:href="pdb:3MQM">3MQM</ext-link> (ASH1L), <ext-link ext-link-type="uri" xlink:href="pdb:3MB3">3MB3</ext-link> (PHIP(2)), <ext-link ext-link-type="uri" xlink:href="pdb:3UVD">3UVD</ext-link> (SMARCA4), <ext-link ext-link-type="uri" xlink:href="pdb:3NXB">3NXB</ext-link> (CECR2), <ext-link ext-link-type="uri" xlink:href="pdb:3Q2E">3Q2E</ext-link> (WDR9(2)), <ext-link ext-link-type="uri" xlink:href="pdb:3UV5">3UV5</ext-link> (TAF1(1/2)), <ext-link ext-link-type="uri" xlink:href="pdb:3RCW">3RCW</ext-link> (BRD1), <ext-link ext-link-type="uri" xlink:href="pdb:3UVW">3UVW</ext-link> (BRD4(1)/H4K5<sub>ac</sub>K8<sub>ac</sub>), <ext-link ext-link-type="uri" xlink:href="pdb:3UVX">3UVX</ext-link> (BRD4(1)/H4K12<sub>ac</sub>K16<sub>ac</sub>), <ext-link ext-link-type="uri" xlink:href="pdb:3UVY">3UVY</ext-link> (BRD4(1)/H4K16<sub>ac</sub>K20<sub>ac</sub>), <ext-link ext-link-type="uri" xlink:href="pdb:3UW9">3UW9</ext-link> (BRD4(1)/H4K8<sub>ac</sub>K12<sub>ac</sub>), <ext-link ext-link-type="uri" xlink:href="pdb:3P1C">3P1C</ext-link> (CREBBP/K<sub>ac</sub>), <ext-link ext-link-type="uri" xlink:href="pdb:3P1D">3P1D</ext-link> (CREBBP/N-Methyl-2-pyrrolidone), and <ext-link ext-link-type="uri" xlink:href="pdb:3MB4">3MB4</ext-link> (PB1(5)/N-Methyl-2-pyrrolidone).</p>
    </sec>
    <sec id="app3" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Table S1. Cloning Information of BRD Constructs, Related to Experimental Procedures</title>
          </caption>
          <media xlink:href="mmc1.xls"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Table S2. Expression and Purification Details for Studied Human BRDs, Related to Experimental Procedures</title>
          </caption>
          <media xlink:href="mmc2.xls"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc3">
          <caption>
            <title>Table S5. Diffraction and refinement statistics for crystallized human BRDs, Related to Experimental Procedures</title>
          </caption>
          <media xlink:href="mmc3.xls"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc4">
          <caption>
            <title>Document S1. Tables S3, S4, and S6âS9</title>
          </caption>
          <media xlink:href="mmc4.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc5">
          <caption>
            <title>Document S2. Article plus Supplemental Information</title>
          </caption>
          <media xlink:href="mmc5.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>The SGC is a registered charity (number 1097737) that receives funds from theÂ Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, the Novartis Research Foundation, the Ontario Ministry of Research and Innovation, and the Wellcome Trust. P.F. is supported by a Wellcome Trust Career Development Fellowship (095751/Z/11/Z). T.P. and A.-C.G. are supported by a Global Leadership Round in Genomics and Life Sciences from the Ontario Ministry of Health and Innovation. J.-P.L. is supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada. A.-C.G. and C.H.A. hold Canada Research Chairs in Functional Proteomics and Structural Proteomics, respectively.</p>
    </ack>
    <fn-group>
      <fn id="app2" fn-type="supplementary-material">
        <p>Supplemental Information includes Extended Experimental Procedures, seven supplemental figures, and nine supplemental tables and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.cell.2012.02.013">doi:10.1016/j.cell.2012.02.013</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>FigureÂ 1</label>
      <caption>
        <p>Domain Organization, Phylogenetic Tree, and Overall Fold of BRDs</p>
        <p>(A) Domain organization of representative proteins that contain BRDs. The name and the length of the selected proteins are shown on the bar chart in the left panel. The positions of the different domains are highlighted as shown by the legend on the right.</p>
        <p>(B) Phylogenetic tree of the human BRD family. The different families are named by Roman numbers (IâVIII). Structures determined in this study, by NMR, or by other groups are indicated by blue, red, and green dots, respectively.</p>
        <p>(C) Domain flexibility as seen in the tandem BRD modules of TAF1 di-domain structure (orange PDB: <ext-link ext-link-type="uri" xlink:href="pdb:1EQF">1EQF</ext-link>) and a new structure (green PDB: <ext-link ext-link-type="uri" xlink:href="pdb:3UV5">3UV5</ext-link>), highlighting the ability of BRDs to adopt different relative orientations that may influence the recognition of their target sequences.</p>
        <p>(D) Overall structure of the BRD4(1) BRD. N and C termini and secondary structure elements are labeled.</p>
        <p>See also <xref rid="figs1" ref-type="fig">FigureÂ S1</xref>.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>FigureÂ 2</label>
      <caption>
        <p>Electrostatic Surface Potential of Human BRDs</p>
        <p>The domains are grouped into the eight BRD families (shown in roman numerals). Electrostatic surface potentials are shown between â10kT/e (red) andÂ +10kT/e (blue). The BRD names and structures (PDB accession code in black for crystal structures and red for NMR models) are shown in the figure. All domains are shown in identical orientation with their acetyl-lysine binding site facing the reader and highlighted with a dashed circle on the top-left structure (PCAF). See also <xref rid="figs3" ref-type="fig">FigureÂ S3</xref>.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>FigureÂ 3</label>
      <caption>
        <p>Conserved Residues and Sequence Logos</p>
        <p>Conserved residues are shown as sequence logos (lower panel in each figure), and their location is shown in the ribbon diagram above. Secondary structure elements and residue labels are colored in all figures as follows: Î±<sub>Z</sub>, blue; Î±<sub>A</sub>, pink; Î±<sub>B</sub>, green; Î±<sub>C</sub>, brown; ZA loop, magenta. Motifs and location of residues are shown for (A) ZA loop, (B) helix Î±<sub>A</sub> and AB loop, (C) AB loop and helix Î±<sub>B</sub>, and (D) helix C. The conserved K<sub>ac</sub> docking residue (N140) is shown in cyan. See also <xref rid="figs2" ref-type="fig">FigureÂ S2</xref>.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>FigureÂ 4</label>
      <caption>
        <p>Detected Interactions of BRDs with Histones in SPOT Arrays</p>
        <p>A total of 33 BRDs were screened against an array of singly acetylated peptides that cover all possible acetylation sites in histones H1.4 (right panel), H2A, H2B, H3, and H4 (left panel). Non-K<sub>ac</sub> specific interaction (corresponding nonacetylated) peptides are shaded in gray. Spots are shaded by different spot intensities as indicated in the figure. See also <xref rid="figs4" ref-type="fig">FigureÂ S4</xref>.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>FigureÂ 5</label>
      <caption>
        <p>Influence of Neighboring PTMs on BRD Interaction with Histone H3</p>
        <p>Shown are interactions detected in SPOT arrays shaded by spot intensity as indicated in the legend at the upper-left corner of the figure. The influence of lysine trimethylation (K<sub>me3</sub>), acetylation, and phosphorylation (pT, pS) has been studied on binding to a central acetylated lysine epitope. The combination of the different modifications is indicated in the right panel. Nonmodified peptides have been included as controls to identify interactions independent of lysine acetylation. See also <xref rid="figs5" ref-type="fig">FigureÂ S5</xref>.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>FigureÂ 6</label>
      <caption>
        <p>Binding of the N- and C-BRDs of BRD4 to Multiply Acetylated Histone H3 and H4</p>
        <p>(A) Interactions detected in microSPOT arrays for BRD4(1) and BRD4(2) comprising multiply acetylated histone H3 (shown in green) or H4 (shown in blue) peptides.</p>
        <p>(B) Peptide lengths are given together with the location of the K<sub>ac</sub> marks (green hexagons). Binding of seven BRD members of the BET subfamily is summarized, highlighting the effect of multiple K<sub>ac</sub> marks as well as neighboring Ser or Thr phosphorylation.</p>
        <p>(C) Structural overlay of diacetylated peptides to the K<sub>ac</sub> binding site of BRD4(1). The binding mode is retained, although the linker between marks and the flanking residues are not the same.</p>
        <p>(D) Two representative ITC traces of polyacetylated histone H4 peptide binding to BRD4(1). Peptide sequences are shown in the inset.</p>
        <p>See also <xref rid="figs6" ref-type="fig">FigureÂ S6</xref>.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="fig7">
      <label>FigureÂ 7</label>
      <caption>
        <p>Effect of Distance between Acetylated Lysines and InÂ Vivo Binding of BRD4</p>
        <p>(A) Effect of poly-Gly and linker sequence on binding of doubly acetylated peptides to BET BRDs profiled by SPOT assays. Interactions are weakened or abolished when the docking asparagine is mutated to an Ala (N140A for the first and N433A for the second BRDs of BRD4).</p>
        <p>(B) Effect of poly-Gly linker on the binding of H4K5<sub>ac</sub>K8<sub>ac</sub> to BRD4(1) evaluated by ITC, demonstrating that the natural recognition sequence has the optimal sequence for binding. Peptide sequences are given in the inset.</p>
        <p>(C) The second BRD of BRD4 is more promiscuous as demonstrated by ITC, exhibiting weaker binding for all tested peptides.</p>
        <p>(D) Immunoprecipitation of Flag-tagged BRD4 from transfected cell nucleosome fraction and western blotting using anti-acetylated histone antibodies. Input represents 1% of total input. IgG was used for control immunoprecipitations.</p>
        <p>(E) Individual BRD4 BRDs purify histones with distinct acetylation status from histone fractions. Acetylated histone peptides associated with biotinylated BRD4(1) or BRD4(2) were identified by LC-MS/MS, and the relative peak intensity of individual peptides was expressed as a ratio of peak area of the specific peptide to the sum of all peak areas for acetylated histone peptides in each sample.</p>
        <p>See also <xref rid="figs7" ref-type="fig">FigureÂ S7</xref>.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <fig id="figs1">
      <label>FigureÂ S1</label>
      <caption>
        <p>Structure-Guided Sequence Alignment of the Human Bromodomain Family, Related to <xref rid="fig1" ref-type="fig">FigureÂ 1</xref></p>
        <p>Sequences are clustered by BRD families, highlighted by different colors corresponding to the eight families (Roman numbers IâVIII). The sequence region used for the generation of the phylogenetic tree is indicated by arrows. Location of bromodomain structural elements are shown and named on the top of the figure. Helices are indicated with solid black boxes (extracted from crystal structures) or red dashed boxes (predicted using PSIPRED) (<xref rid="bib33" ref-type="bibr">Jones, 1999</xref>). Available representative structures (pdb-accession codes) are shown on the right (crystal structures in black and NMR models in red). The first bromodomain of BRD4 (bold and highlighted by an arrow) has been chosen as a reference sequence and the corresponding numbering is shown on top of the alignment. The red asterisk indicates a unique 17 residue insertion between helices B and C in the case of TRIM33A.</p>
      </caption>
      <graphic xlink:href="figs1"/>
    </fig>
    <fig id="figs2">
      <label>FigureÂ S2</label>
      <caption>
        <p>Structural Conservation in Helix Î±Z and the ZA Loop Region, Related to <xref rid="fig3" ref-type="fig">FigureÂ 3</xref></p>
        <p>(A) Structural overview of the BRD4(1) bromodomain. Secondary structure elements and residue labels are colored as follows: Î±<sub>Z</sub> blue, Î±<sub>A</sub> pink, Î±<sub>B</sub> green, Î±<sub>C</sub>Â brown, ZA loop magenta.</p>
        <p>(B) Sequence conservation in helix Î±<sub>Z</sub>.</p>
        <p>(C) Anchoring of the ZA loop to the bromodomain core. Shown are two orientations (left and right panel) of the ZA loop and its interaction with the core structure (shown as surface). The surface is colored according to the structural elements that harbor the depicted surface residues as described in panel A.</p>
        <p>(D) Sequence conservation of for the entire family of human BRDs. Regions of low or no conservation are annotated (in pink), highlighting the advantage of employing structural and structure prediction data to define the structurally conserved BRD module.</p>
      </caption>
      <graphic xlink:href="figs2"/>
    </fig>
    <fig id="figs3">
      <label>FigureÂ S3</label>
      <caption>
        <p>Overall Structure of Human Bromodomains, Related to <xref rid="fig2" ref-type="fig">FigureÂ 2</xref></p>
        <p>(A) Ribbon diagrams of all publicly available crystal (black labels) and NMR (red labels) structures.</p>
        <p>(B) Structural Overlay of ASH1L and the reference structure of BRD4(1). The hairpin insert, a hall mark of bromodomains of family VIII is highlighted and details are shown in the expanded view on the left panel.</p>
      </caption>
      <graphic xlink:href="figs3"/>
    </fig>
    <fig id="figs4">
      <label>FigureÂ S4</label>
      <caption>
        <p>SPOT Membrane Layout of <xref rid="fig4" ref-type="fig">FigureÂ 4</xref> and Representative Membranes for Each Family of BRDs, Related to <xref rid="fig4" ref-type="fig">FigureÂ 4</xref></p>
        <p>Top panel: Core (H2A, H2B, H3 and H4) and linker (H1.4) histone sequences used in the SPOT membranes of <xref rid="fig4" ref-type="fig">FigureÂ 4</xref> are shown with K<sub>ac</sub> residues numbered (in the template) and highlighted (on the sequences) with a green hexagon. Boxes without a number represent control (nonacetylated) peptides for the histone marks following in the array. Lower panel: Representative membranes for each subfamily are given as follows: family I - FALZ, family II - BRDT(1), family III - EP300, family IV - BRPF1A, family V - LOC93349, family VI - MLL, family VII - TAF1L(2) and family VIII - SMARCA2A.</p>
      </caption>
      <graphic xlink:href="figs4"/>
    </fig>
    <fig id="figs5">
      <label>FigureÂ S5</label>
      <caption>
        <p>microSPOT Membrane Layout of <xref rid="fig5" ref-type="fig">FigureÂ 5</xref> and Representative Membranes for Each Family of BRDs, Related to <xref rid="fig5" ref-type="fig">FigureÂ 5</xref></p>
        <p>Top Panel: The N-terminal sequence of human histone 3 is shown with highlighted marks that were studied for crosstalk, including lysine acetylation and (tri-)methylation as well as threonine and serine phosphorylation. Peptide sequences are given in the inset of <xref rid="fig5" ref-type="fig">FigureÂ 5</xref>. The membrane layout highlights the position of central epitopes (numbered). The blow-up shows as an example the arrangement of marks around the H3K14<sub>ac</sub> epitope. Lower panel: Representative membranes for each subfamily are given as follows: family I - CECR2, family II - BRD4(2), family III - WDR9(2), family IV - BRD9, family V - BAZ2B, family VIÂ -Â TRIM28, family VII - TAF1(1) and family VIII - PB1(4).</p>
      </caption>
      <graphic xlink:href="figs5"/>
    </fig>
    <fig id="figs6">
      <label>FigureÂ S6</label>
      <caption>
        <p>Binding of BRDs to Diacetylated H4 Peptides, Related to <xref rid="fig6" ref-type="fig">FigureÂ 6</xref></p>
        <p>(A) Detail from the crystal structure of H4<sub>1-11</sub>K5<sub>ac</sub>K8<sub>ac</sub> binding to BRD4(1). The protein surface has been colored according to its electrostatic properties and key residues are annotated.</p>
        <p>(B) Detail of H4<sub>11-21</sub>K12<sub>ac</sub>K16<sub>ac</sub> binding to the surface of BRD4(1).</p>
        <p>(C) Detail of H4<sub>15-25</sub>K16<sub>ac</sub>K20<sub>ac</sub> binding to the surface of BRD4(1).</p>
        <p>(D) Binding of two BRD4(1) modules to the H4<sub>7-17</sub>K8<sub>ac</sub>K12<sub>ac</sub> peptide.</p>
      </caption>
      <graphic xlink:href="figs6"/>
    </fig>
    <fig id="figs7">
      <label>FigureÂ S7</label>
      <caption>
        <p>SPOT Membrane Layout of <xref rid="fig7" ref-type="fig">FigureÂ 7</xref> and Membranes for Each BET Bromodomain, Related to <xref rid="fig7" ref-type="fig">FigureÂ 7</xref></p>
        <p>Membrane layout (top) of the peptides used to probe the effect on binding of a poly-glycine linker and of different residue properties between two acetyl-lysine marks on histone H4. Stained membranes of BET family bromodomains and the two inactive mutants of BRD4 are given in the lower panel.</p>
      </caption>
      <graphic xlink:href="figs7"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Human Bromodomain Family</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th>Protein</th>
            <th>Name</th>
            <th>Alias</th>
            <th>Protein Function</th>
            <th>Subcellular Localization<xref rid="tblfn1" ref-type="table-fn">a</xref></th>
            <th>UniProt ID</th>
            <th>Reference</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>ASH1L</td>
            <td>ash1 (absent, small, or homeotic)-like</td>
            <td>ASH1, KMT2H</td>
            <td>Methyltransferase</td>
            <td>N, C</td>
            <td>Q9NR48</td>
            <td>(<xref rid="bib25" ref-type="bibr">Gregory etÂ al., 2007</xref>)</td>
          </tr>
          <tr>
            <td>ATAD2</td>
            <td>Two AAA domain containing protein</td>
            <td>ANCCA</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>Q6PL18</td>
            <td>(<xref rid="bib11" ref-type="bibr">CirÃ³ etÂ al., 2009</xref>)</td>
          </tr>
          <tr>
            <td>BAZ1A</td>
            <td>Bromodomain adjacent to zinc finger domain, 1A</td>
            <td>ACF1, WALp1, WCRF180</td>
            <td>Chromatin remodeling factor</td>
            <td>N</td>
            <td>Q9NRL2</td>
            <td>(<xref rid="bib62" ref-type="bibr">Racki etÂ al., 2009</xref>)</td>
          </tr>
          <tr>
            <td>BAZ1B</td>
            <td>Bromodomain adjacent to zinc finger domain, 1B</td>
            <td>WSTF, WBSCR9</td>
            <td>Chromatin remodeling factor, transcriptional regulator</td>
            <td>N</td>
            <td>Q9UIG0</td>
            <td>(<xref rid="bib8" ref-type="bibr">CavellÃ¡n etÂ al., 2006</xref>)</td>
          </tr>
          <tr>
            <td>BAZ2A</td>
            <td>Bromodomain adjacent to zinc finger domain, 2A</td>
            <td>TIP5, WALp3</td>
            <td>Transcriptional repressor</td>
            <td>N, C</td>
            <td>Q9UIF9</td>
            <td>(<xref rid="bib84" ref-type="bibr">Zhou etÂ al., 2009</xref>)</td>
          </tr>
          <tr>
            <td>BAZ2B</td>
            <td>Bromodomain adjacent to zinc finger domain, 2B</td>
            <td>WALp4</td>
            <td>Unknown</td>
            <td>N, C</td>
            <td>Q9UIF8</td>
            <td>(<xref rid="bib34" ref-type="bibr">Jones etÂ al., 2000</xref>)</td>
          </tr>
          <tr>
            <td>BRD1</td>
            <td>Bromodomain-containing protein 1</td>
            <td>BRL, BRPF2</td>
            <td>Transcriptional regulator, scaffold protein</td>
            <td>N, C</td>
            <td>O95696</td>
            <td>(<xref rid="bib74" ref-type="bibr">Ullah etÂ al., 2008</xref>)</td>
          </tr>
          <tr>
            <td>BRD2</td>
            <td>Bromodomain-containing protein 2</td>
            <td>FSH, RING3</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>P25440</td>
            <td>(<xref rid="bib44" ref-type="bibr">LeRoy etÂ al., 2008</xref>)</td>
          </tr>
          <tr>
            <td>BRD3</td>
            <td>Bromodomain-containing protein 3</td>
            <td>ORFX, RING3L</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>Q15059</td>
            <td>(<xref rid="bib44" ref-type="bibr">LeRoy etÂ al., 2008</xref>)</td>
          </tr>
          <tr>
            <td>BRD4</td>
            <td>Bromodomain-containing protein 4</td>
            <td>CAP, MCAP, HUNK1</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>O60885</td>
            <td>(<xref rid="bib81" ref-type="bibr">Yang etÂ al., 2008</xref>)</td>
          </tr>
          <tr>
            <td>BRD7</td>
            <td>Bromodomain-containing protein 7</td>
            <td>BP75, NAG4, CELTIX1</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>Q9NPI1</td>
            <td>(<xref rid="bib35" ref-type="bibr">Kaeser etÂ al., 2008</xref>)</td>
          </tr>
          <tr>
            <td>BRD8B</td>
            <td>Bromodomain-containing protein 8 B</td>
            <td>SMAP, SMAP2</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>Q9H0E9-2</td>
            <td>(<xref rid="bib7" ref-type="bibr">Cai etÂ al., 2003</xref>)</td>
          </tr>
          <tr>
            <td>BRD9</td>
            <td>Bromodomain-containing protein 9</td>
            <td/>
            <td>Unknown</td>
            <td>N, C</td>
            <td>Q9H8M2</td>
            <td>NA</td>
          </tr>
          <tr>
            <td>BRDT</td>
            <td>Bromodomain-containing protein, testis specific</td>
            <td>BRD6</td>
            <td>Chromatin remodeling factor</td>
            <td>N</td>
            <td>Q58F21</td>
            <td>(<xref rid="bib51" ref-type="bibr">MoriniÃ¨re etÂ al., 2009</xref>)</td>
          </tr>
          <tr>
            <td>BRPF1</td>
            <td>Bromodomain- and PHD finger-containing protein 1A</td>
            <td>BR140, Peregrin</td>
            <td>Transcriptional activator</td>
            <td>N, C</td>
            <td>P55201-1</td>
            <td>(<xref rid="bib43" ref-type="bibr">Laue etÂ al., 2008</xref>)</td>
          </tr>
          <tr>
            <td>BRPF3</td>
            <td>Bromodomain- and PHD finger-containing protein, 3</td>
            <td/>
            <td>Unknown</td>
            <td>N</td>
            <td>Q9ULD4</td>
            <td>NA</td>
          </tr>
          <tr>
            <td>BRWD3</td>
            <td>Bromodomain-containing protein disrupted in leukemia</td>
            <td>BRODL</td>
            <td>JAK-STAT signaling</td>
            <td>N, C</td>
            <td>Q6RI45</td>
            <td>(<xref rid="bib54" ref-type="bibr">MÃ¼ller etÂ al., 2005</xref>)</td>
          </tr>
          <tr>
            <td>CECR2</td>
            <td>Cat eye syndrome chromosome region</td>
            <td/>
            <td>Chromatin remodeling factor</td>
            <td>N</td>
            <td>Q9BXF3</td>
            <td>(<xref rid="bib17" ref-type="bibr">Fairbridge etÂ al., 2010</xref>)</td>
          </tr>
          <tr>
            <td>CREBBP</td>
            <td>CREB-binding protein</td>
            <td>CBP, KAT3A</td>
            <td>Histone acetyl transferase</td>
            <td>N</td>
            <td>Q92793</td>
            <td>(<xref rid="bib36" ref-type="bibr">Kalkhoven, 2004</xref>)</td>
          </tr>
          <tr>
            <td>EP300</td>
            <td>E1A-binding protein p300</td>
            <td>p300, KAT3B</td>
            <td>Histone acetyl transferase</td>
            <td>N</td>
            <td>Q09472</td>
            <td>(<xref rid="bib36" ref-type="bibr">Kalkhoven, 2004</xref>)</td>
          </tr>
          <tr>
            <td>FALZ</td>
            <td>Fetal Alzheimer antigen</td>
            <td>BPTF, FAC1</td>
            <td>Transcription factor</td>
            <td>N</td>
            <td>Q12830</td>
            <td>(<xref rid="bib45" ref-type="bibr">Li etÂ al., 2006</xref>)</td>
          </tr>
          <tr>
            <td>GCN5L2</td>
            <td>General control of amino acid synthesis 5-like 2</td>
            <td>KAT2A, GCN5</td>
            <td>Histone acetyl transferase</td>
            <td>N</td>
            <td>Q92830</td>
            <td>(<xref rid="bib80" ref-type="bibr">Yang etÂ al., 1996</xref>)</td>
          </tr>
          <tr>
            <td>KIAA1240</td>
            <td>KIAA1240 protein</td>
            <td>ATAD2B</td>
            <td>Unknown</td>
            <td>N</td>
            <td>Q9ULI0</td>
            <td>NA</td>
          </tr>
          <tr>
            <td>LOC93349</td>
            <td>SP140-like</td>
            <td>SP140L</td>
            <td>Unknown</td>
            <td>U</td>
            <td>Q13342</td>
            <td>NA</td>
          </tr>
          <tr>
            <td>MLL</td>
            <td>Myeloid/lymphoid or mixed lineage leukemia (trithorax homolog, <italic>Drosophila</italic>)</td>
            <td>HRX, TRX1, CXXC7, ALL-1</td>
            <td>Histone methyl transferase</td>
            <td>N</td>
            <td>Q03164</td>
            <td>(<xref rid="bib15" ref-type="bibr">Dou etÂ al., 2005</xref>)</td>
          </tr>
          <tr>
            <td>PB1</td>
            <td>Polybromo 1</td>
            <td>PBRM1, BAF180</td>
            <td>Chromatin remodeling factor</td>
            <td>N, C</td>
            <td>Q86U86</td>
            <td>(<xref rid="bib79" ref-type="bibr">Xue etÂ al., 2000</xref>)</td>
          </tr>
          <tr>
            <td>PCAF</td>
            <td>P300/CBP-associated factor</td>
            <td>KAT2B</td>
            <td>Histone acetyl transferase</td>
            <td>N</td>
            <td>Q92831</td>
            <td>(<xref rid="bib14" ref-type="bibr">Dhalluin etÂ al., 1999</xref>)</td>
          </tr>
          <tr>
            <td>PHIP</td>
            <td>Pleckstrin homology domain-interacting protein</td>
            <td>WDR11, ndrp</td>
            <td>Insulin signaling</td>
            <td>N</td>
            <td>Q8WWQ0</td>
            <td>(<xref rid="bib61" ref-type="bibr">Podcheko etÂ al., 2007</xref>)</td>
          </tr>
          <tr>
            <td>PRKCBP1</td>
            <td>Protein kinase C-binding protein 1</td>
            <td>ZMYND8, RACK7</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>Q9ULU4</td>
            <td>(<xref rid="bib20" ref-type="bibr">Fossey etÂ al., 2000</xref>)</td>
          </tr>
          <tr>
            <td>SMARCA2</td>
            <td>SWI/SNF-related matrix-associated actin-dependent regulator of chromatin a2</td>
            <td>BRM, SNF2L2</td>
            <td>Chromatin remodeling factor, Splicing regulator</td>
            <td>N</td>
            <td>P51531</td>
            <td>(<xref rid="bib26" ref-type="bibr">Harikrishnan etÂ al., 2005</xref>)</td>
          </tr>
          <tr>
            <td>SMARCA4</td>
            <td>SWI/SNF-related matrix-associated actin-dependent regulator of chromatin a4</td>
            <td>BRG1, SNF2L4, SNF2LB</td>
            <td>Chromatin remodeling factor</td>
            <td>N</td>
            <td>P51532</td>
            <td>(<xref rid="bib63" ref-type="bibr">Rada-Iglesias etÂ al., 2011</xref>)</td>
          </tr>
          <tr>
            <td>SP100</td>
            <td>Nuclear antigen Sp100</td>
            <td/>
            <td>Transcriptional regulator</td>
            <td>N, C</td>
            <td>P23497</td>
            <td>(<xref rid="bib82" ref-type="bibr">Yordy etÂ al., 2005</xref>)</td>
          </tr>
          <tr>
            <td>SP110</td>
            <td>Nuclear antigen Sp110 A, nuclear antigen Sp110 C</td>
            <td>IPR1</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>Q9HB58</td>
            <td>(<xref rid="bib6" ref-type="bibr">Bloch etÂ al., 2000</xref>)</td>
          </tr>
          <tr>
            <td>SP140</td>
            <td>SP140 nuclear body protein</td>
            <td>LYSP100</td>
            <td>Transcriptional regulator</td>
            <td>N, C</td>
            <td>Q13342</td>
            <td>(<xref rid="bib86" ref-type="bibr">Zong etÂ al., 2000</xref>)</td>
          </tr>
          <tr>
            <td>TAF1</td>
            <td>TAF1 RNA polymerase II, TATA box-binding protein (TBP)-associated factor</td>
            <td>TAFII250</td>
            <td>Transcription initiation</td>
            <td>N</td>
            <td>P21675</td>
            <td>(<xref rid="bib78" ref-type="bibr">Wassarman and Sauer, 2001</xref>)</td>
          </tr>
          <tr>
            <td>TAF1L</td>
            <td>TAF1-like RNA polymerase II, TATA box-binding protein (TBP)-associated factor</td>
            <td>TAF(II)210</td>
            <td>Transcription initiation</td>
            <td>N</td>
            <td>Q8IZX4</td>
            <td>(<xref rid="bib76" ref-type="bibr">Wang and Page, 2002</xref>)</td>
          </tr>
          <tr>
            <td>TIF1Î±</td>
            <td>Transcriptional intermediary factor 1</td>
            <td>TRIM24, PTC6, RNF82,</td>
            <td>Transcriptional regulator</td>
            <td>N, C</td>
            <td>O15164</td>
            <td>(<xref rid="bib73" ref-type="bibr">Tsai etÂ al., 2010</xref>)</td>
          </tr>
          <tr>
            <td>TRIM28</td>
            <td>Tripartite motif-containing 28</td>
            <td>KAP1, RNF96, TIF1Î²</td>
            <td>Transcriptional regulator</td>
            <td>N</td>
            <td>Q13263</td>
            <td>(<xref rid="bib66" ref-type="bibr">Rowe etÂ al., 2010</xref>)</td>
          </tr>
          <tr>
            <td>TRIM33</td>
            <td>Tripartite motif-containing 33 A</td>
            <td>PTC7, RFG7, TIF1Î³</td>
            <td>Control of transcription elongation</td>
            <td>N</td>
            <td>Q9UPN9</td>
            <td>(<xref rid="bib1" ref-type="bibr">Bai etÂ al., 2010</xref>)</td>
          </tr>
          <tr>
            <td>TRIM66</td>
            <td>Tripartite motif-containing 66</td>
            <td>TIF1Î´</td>
            <td>Transcriptional repressor</td>
            <td>N</td>
            <td>O15016</td>
            <td>(<xref rid="bib38" ref-type="bibr">Khetchoumian etÂ al., 2004</xref>)</td>
          </tr>
          <tr>
            <td>WDR9</td>
            <td>WD repeat domain 9</td>
            <td>BRWD1</td>
            <td>Chromatin remodeling factor</td>
            <td>N</td>
            <td>Q9NSI6</td>
            <td>(<xref rid="bib29" ref-type="bibr">Huang etÂ al., 2003</xref>)</td>
          </tr>
          <tr>
            <td>ZMYND11</td>
            <td>Zinc finger, MYND domain containing 11</td>
            <td>BS69, BRAM1</td>
            <td>Transcriptional repressor</td>
            <td>N</td>
            <td>Q15326</td>
            <td>(<xref rid="bib49" ref-type="bibr">Masselink and Bernards, 2000</xref>)</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <label>a</label>
          <p>Nuclear (N) or cytoplasmic (C).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>